Настройки

Укажите год
-

Небесная энциклопедия

Космические корабли и станции, автоматические КА и методы их проектирования, бортовые комплексы управления, системы и средства жизнеобеспечения, особенности технологии производства ракетно-космических систем

Подробнее
-

Мониторинг СМИ

Мониторинг СМИ и социальных сетей. Сканирование интернета, новостных сайтов, специализированных контентных площадок на базе мессенджеров. Гибкие настройки фильтров и первоначальных источников.

Подробнее

Форма поиска

Поддерживает ввод нескольких поисковых фраз (по одной на строку). При поиске обеспечивает поддержку морфологии русского и английского языка
Ведите корректный номера.
Ведите корректный номера.
Ведите корректный номера.
Ведите корректный номера.
Укажите год
Укажите год

Применить Всего найдено 32539. Отображено 100.
10-02-2006 дата публикации

ВЫПАРНАЯ УСТАНОВКА ДЛЯ ПЕРЕРАБОТКИ СМЕСИ МАТОЧНЫХ ПЕНТАЭРИТРИТО-ФОРМИАТНЫХ РАСТВОРОВ

Номер: RU0000051346U1

1. Выпарная установка для переработки смеси маточных пентаэритрито-формиатных растворов, содержащая две ступени последовательно соединенных по ходу раствора и пара выпарных аппаратов с вертикальными трубами, вторая ступень которой представляет собой кристаллизатор, снабженный циркуляционным контуром с насосом и паровым сепаратором, соединенным паропроводом с концевым конденсатором, отличающаяся тем, что первая ступень состоит из аппаратов с пленочным течением жидкости, а вторая ступень снабжена дополнительным кристаллизатором с циркуляционным контуром, имеющим насос, и дополнительным конденсатором, соединенным с паровым сепаратором дополнительного кристаллизатора и оснащенным устройством для вывода неконденсирующихся газов, причем последний аппарат первой ступени снабжен дополнительным трубопроводом отвода вторичного пара, сообщенным с греющей камерой дополнительного кристаллизатора. 2. Выпарная установка по п.1, отличающаяся тем, что на дополнительном трубопроводе вторичного пара установлено устройство для регулирования потока. 3. Выпарная установка по п.1, отличающаяся тем, что растворный объем дополнительного кристаллизатора в 1,5-2,5 раза больше, чем первого. 4. Выпарная установка по п.1, отличающаяся тем, что первый кристаллизатор снабжен вынесенным гидроциклоном, подводящий патрубок которого соединен с нагнетательной камерой циркуляционного насоса, песковый - с всасывающей камерой насоса, а патрубок осветленного раствора - с патрубком вывода упаренного раствора. 5. Выпарная установка по п.1, отличающаяся тем, что выхлоп устройства для удаления неконденсирующихся газов из дополнительного конденсатора сообщен с концевым конденсатором. РОССИЙСКАЯ ФЕДЕРАЦИЯ (19) RU (11) 51 346 (13) U1 (51) МПК B01D 1/26 (2006.01) B01D 9/02 (2006.01) C07C 31/24 (2006.01) ФЕДЕРАЛЬНАЯ СЛУЖБА ПО ИНТЕЛЛЕКТУАЛЬНОЙ СОБСТВЕННОСТИ, ПАТЕНТАМ И ТОВАРНЫМ ЗНАКАМ (12) ОПИСАНИЕ ПОЛЕЗНОЙ МОДЕЛИ К ПАТЕНТУ (21), (22) Заявка: 2005124430/22 , 01.08.2005 (24) Дата начала отсчета срока действия патента ...

Подробнее
27-07-2006 дата публикации

ТЕХНОЛОГИЧЕСКАЯ ЛИНИЯ ПОЛУЧЕНИЯ N`-МЕТИЛ-1-ФЕНИЛ-1-N, N-ДИЭТИЛАМИНОМЕТАНСУЛЬФОНАМИДА (ВАРИАНТЫ)

Номер: RU0000054940U1

1. Технологическая линия получения N'-метил-1-фенил-1-N,N-диэтиламинометансульфонамида, включающая последовательно соединенные: реактор для получения раствора комплекса диэтиламина с SO, оборудованный устройством для подачи газообразного SO, дозаторами для подачи диэтиламина и растворителя, мерник для дозирования раствора комплекса диэтиламина с SO, реактор для синтеза N'-метил-1-фенил-1-N,N-диэтиламинометансульфонамида, оборудованный мерниками для подачи бензальметиламина и воды, охлаждаемый реактор интенсивного смешения, подогреваемый реактор интенсивного смешения. 2. Технологическая линия получения N'-метил-1-фенил-1-N,N-диэтиламинометансульфонамида, включающая последовательно соединенные: реактор для получения раствора комплекса диэтиламина с SO, оборудованный устройством для подачи газообразного SO, дозаторами для подачи диэтиламина и растворителя, мерник для дозирования раствора комплекса диэтиламина с SO, реактор для синтеза N'-метил-1-фенил-1-N,N-диэтиламинометансульфонамида, оборудованный мерниками для подачи бензальметиламина и воды, охлаждаемый реактор интенсивного смешения, реактор-перекристаллизатор, оборудованный мерником для подачи растворителя, устройство для фильтрования, имеющее три выхода, соединенные с емкостью для отстоя, устройством для регенерации растворителя и подогреваемым реактором интенсивного смешения. РОССИЙСКАЯ ФЕДЕРАЦИЯ (19) RU (11) 54 940 (13) U1 (51) МПК C07C 311/03 C07C 311/05 C07C 311/32 (2006.01) (2006.01) (2006.01) ФЕДЕРАЛЬНАЯ СЛУЖБА ПО ИНТЕЛЛЕКТУАЛЬНОЙ СОБСТВЕННОСТИ, ПАТЕНТАМ И ТОВАРНЫМ ЗНАКАМ (12) ОПИСАНИЕ ПОЛЕЗНОЙ МОДЕЛИ К ПАТЕНТУ (21), (22) Заявка: 2005138221/22 , 22.11.2005 (24) Дата начала отсчета срока действия патента: 22.11.2005 (45) Опубликовано: 27.07.2006 (73) Патентообладатель(и): Общество с ограниченной ответственностью "ФОСФОРОС" (ООО "ФОСФОРОС") (RU) U 1 5 4 9 4 0 R U дозаторами для подачи диэтиламина и растворителя, мерник для дозирования раствора комплекса диэтиламина с SO2, реактор для синтеза N'-метил-1-фенил ...

Подробнее
10-12-2006 дата публикации

УСТАНОВКА ДЛЯ ПЕРЕРАБОТКИ ПРИРОДНОГО ГАЗА (ВАРИАНТЫ)

Номер: RU0000059049U1

1. Установка для переработки природного газа, включающая блок конверсии сырья в синтез-газ и блок конверсии синтез-газа, отличающаяся тем, что блок конверсии сырья в синтез-газ включает реактор конверсии сырья в синтез-газ, в котором узел подвода тепла в зону реакции образован множеством тепловых труб, общая площадь поверхности которых обеспечивает поступление в зону реакции тепла, необходимого для осуществления реакции конверсии углеводородов сырья в синтез-газ, а блок конверсии синтез-газа включает реактор конверсии синтез-газа, в котором узел отвода тепла из зоны реакции образован множеством тепловых труб, общая площадь поверхности которых обеспечивает отвод тепла, выделяющегося при реакции синтеза кислородсодержащих соединений из синтез-газа. 2. Установка по п.1, отличающаяся тем, что реактор конверсии сырья в синтез-газ и реактор превращения синтез-газа работают в режиме, близком к изотермическому. 3. Установка для переработки природного газа, включающая блок конверсии сырья в синтез-газ и блок конверсии синтез-газа, отличающаяся тем, что блок конверсии сырья в синтез-газ включает реактор конверсии сырья в синтез-газ, в котором узел подвода тепла в зону реакции образован множеством тепловых труб, общая площадь поверхности которых обеспечивает поступление в зону реакции тепла, необходимого для осуществления реакции конверсии углеводородов сырья в синтез-газ, а блок конверсии синтез-газа включает реактор конверсии синтез-газа, в котором узел отвода тепла из зоны реакции образован множеством тепловых труб, общая площадь поверхности которых обеспечивает отвод тепла, выделяющегося при реакции синтеза углеводородов из синтез-газа. 4. Установка по п.3, отличающаяся тем, что реактор конверсии сырья в синтез-газ и реактор превращения синтез-газа работают в режиме, близком к изотермическому. РОССИЙСКАЯ ФЕДЕРАЦИЯ (19) RU (11) 59 049 (13) U1 (51) МПК C07C 31/00 (2006.01) ФЕДЕРАЛЬНАЯ СЛУЖБА ПО ИНТЕЛЛЕКТУАЛЬНОЙ СОБСТВЕННОСТИ, ПАТЕНТАМ И ТОВАРНЫМ ЗНАКАМ (12) ОПИСАНИЕ ПОЛЕЗНОЙ ...

Подробнее
27-02-2007 дата публикации

УСТАНОВКА ОЧИСТКИ УГЛЕВОДОРОДНОГО СЫРЬЯ ОТ СЕРООРГАНИЧЕСКИХ СОЕДИНЕНИЙ

Номер: RU0000061282U1

Установка очистки углеводородного сырья от сероорганических соединений, содержащая блок демеркаптанизации углеводородного сырья раствором щелочи с линиями подачи углеводородного сырья и выхода очищенных углеводородов и насыщенного меркаптидами щелочного раствора, блок адсорбционной осушки очищенных углеводородов с линией выхода осушенных углеводородов, блок регенерации насыщенного меркаптидами щелочного раствора с линиями выхода дисульфидов и регенерированной щелочи на блок демеркаптанизации углеводородного сырья, отличающаяся тем, что она дополнительно содержит блок фракционирования дисульфидов, установленный после блока регенерации насыщенного меркаптидами щелочного раствора, с линиями выхода диметилдисульфидов и кубового остатка, включающий адсорберы, соединенные через трубное пространство рекуперативного теплообменника с ректификационной колонной, верх которой через межтрубное пространство рекуперативного теплообменника, холодильник и рефлюксную емкость соединен с линией выхода диметилдисульфидов, причем последняя соединена линией орошения с верхом ректификационной колонны, низ которой соединен через второй холодильник и вторую рефлюксную емкость с линией выхода кубового остатка. РОССИЙСКАЯ ФЕДЕРАЦИЯ (19) RU (11) 61 282 (13) U1 (51) МПК C10G 27/06 (2006.01) C07C 319/14 (2006.01) ФЕДЕРАЛЬНАЯ СЛУЖБА ПО ИНТЕЛЛЕКТУАЛЬНОЙ СОБСТВЕННОСТИ, ПАТЕНТАМ И ТОВАРНЫМ ЗНАКАМ (12) ОПИСАНИЕ ПОЛЕЗНОЙ МОДЕЛИ К ПАТЕНТУ (21), (22) Заявка: 2006132630/22 , 11.09.2006 (24) Дата начала отсчета срока действия патента: 11.09.2006 (45) Опубликовано: 27.02.2007 U 1 6 1 2 8 2 R U Формула полезной модели Установка очистки углеводородного сырья от сероорганических соединений, содержащая блок демеркаптанизации углеводородного сырья раствором щелочи с линиями подачи углеводородного сырья и выхода очищенных углеводородов и насыщенного меркаптидами щелочного раствора, блок адсорбционной осушки очищенных углеводородов с линией выхода осушенных углеводородов, блок регенерации насыщенного меркаптидами ...

Подробнее
27-07-2007 дата публикации

УСТАНОВКА ПОЛУЧЕНИЯ СИНТЕТИЧЕСКОГО БЕНЗИНА ИЗ АЛИФАТИЧЕСКОГО СПИРТА, В ЧАСТНОСТИ МЕТАНОЛА

Номер: RU0000065045U1

1. Установка получения синтетического бензина из алифатического спирта, включая метанол, включающая каталитический реактор, печь реакторного блока, рекуперативные теплообменники, газосепаратор, ректификационную колонну, холодильник нестабильного катализата, соединенный с каталитическим реактором и газосепаратором, а также теплообменники и соединительные трубопроводы с запорно-регулирующей арматурой, отличающаяся тем, что она содержит воздушный холодильник, соединенный с рекуперативным теплообменником-испарителем и газосепаратором, а также дополнительные холодильники, соединенные с ректификационной колонной, емкость с химически очищенной водой, соединенную с каталитическим реактором, при этом каталитический реактор со стационарным слоем цеолитсодержащего катализатора попеременно работает в режиме реакции и режиме регенерации с отводом тепла реакции с помощью размещенных в нем тепловых труб, а печь реакторного блока соединена через рекуперативные теплообменники с циркуляционным компрессором отделения регенерации блока получения алифатического спирта, в том числе метанола, буферную емкость-сепаратор, соединенную с циркуляционным компрессором и газосепаратором. 2. Установка по п.1, отличающаяся тем, что она снабжена блоком подготовки циркулирующего регенерирующего газа, связанным с каталитическим реактором через рекуперативный теплообменник и циркуляционный компрессор. 3. Установка по п.1, отличающаяся тем, что она содержит линию возврата кубового продукта для осуществления циркуляции. 4. Установка по п.1, отличающаяся тем, что она содержит линию смешения циркулирующего (циркуляционного) газа с алифатическим спиртом, например с метанолом. 5. Установка по п.1, отличающаяся тем, что она содержит линии рецикла (рециркуляции) в каталитический реактор газов сепарации катализата и непрореагировавшего спирта, например метанола, обеспечивающие регулирование температуры и выхода целевого продукта (бензина). РОССИЙСКАЯ ФЕДЕРАЦИЯ (19) RU (11) 65 045 (13) U1 (51) МПК C07C 31/04 ( ...

Подробнее
27-09-2007 дата публикации

УСТАНОВКА ПОЛУЧЕНИЯ ОДОРАНТА ИЗ УГЛЕВОДОРОДОВ

Номер: RU0000066743U1

Установка получения одоранта из углеводородов, содержащая последовательно включенные в технологическую схему блок экстракции легкокипящих меркаптанов, включающий линию подачи углеводородов, колонны, емкость с раствором щелочи, смесители, холодильник, теплообменник, отстойную емкость, линии отвода очищенного стабильного конденсата и выхода насыщенного меркаптидами щелочного раствора, блок регенерации насыщенного меркаптидами щелочного раствора, включающий колонну, отстойник-коагулятор, сборник-накопитель легкокипящих меркаптанов, теплообменники, холодильники, линии отвода регенерированной щелочи в емкость с раствором щелочи на блок экстракции и выхода легкокипящих меркаптанов, блок адсорбционной осушки легкокипящих меркаптанов, включающий накопительные емкости, адсорберы, линии отвода воды и выхода осушенных легкокипящих меркаптанов, блок приема и хранения одоранта, включающий накопительные емкости и узел налива одоранта, а также соединительные трубопроводы и насосы, отличающаяся тем, что она дополнительно содержит установленный между блоками адсорбционной осушки легкокипящих меркаптанов и приема и хранения одоранта блок фракционирования легкокипящих меркаптанов с линиями отвода одоранта и кубового остатка, включающий две ректификационные колонны, низ которых через теплообменники и водяной холодильник соединен с линией отвода кубового остатка, верх первой ректификационной колонны через водяной холодильник, первую рефлюксную емкость и теплообменник соединен со второй ректификационной колонной, верх которой через водяной холодильник и вторую рефлюксную емкость соединен с линией отвода одоранта, причем рефлюксные емкости соединены также с верхом ректификационных колонн. РОССИЙСКАЯ ФЕДЕРАЦИЯ (19) RU (11) 66 743 (13) U1 (51) МПК C07C 319/02 C07C 319/28 (2006.01) (2006.01) ФЕДЕРАЛЬНАЯ СЛУЖБА ПО ИНТЕЛЛЕКТУАЛЬНОЙ СОБСТВЕННОСТИ, ПАТЕНТАМ И ТОВАРНЫМ ЗНАКАМ (12) ОПИСАНИЕ ПОЛЕЗНОЙ МОДЕЛИ К ПАТЕНТУ (21), (22) Заявка: 2006130276/22 , 21.08.2006 (24) Дата начала отсчета срока ...

Подробнее
27-05-2008 дата публикации

ЗАВОД ДЛЯ ПРОИЗВОДСТВА МЕТАНОЛА ИЛИ СИНТЕТИЧЕСКОЙ НЕФТИ

Номер: RU0000073666U1

1. Завод для производства метанола или синтетической нефти, состоящий из производственного здания, которое в свою очередь включает в себя помещения с оборудованием, по крайней мере одно помещение для персонала и по крайней мере один технологический коридор; универсального химического реактора, который состоит из корпуса, торцевых крышек, теплообменного устройства, отсеков для катализатора, обеспечивающих возможность замены последнего, штуцеров для подвода реагентов и отвода продуктов реакции и подвода и отвода теплоносителя, крепежных элементов, причем толщины стенок всех элементов и элементы соединений выполнены с запасом прочности и способными выдерживать совместное давление и температуру, возникающие как при реакции синтеза метанола, так и при реакции синтеза синтетической нефти из синтез-газа, отсеки для катализатора заполнены гранулированным катализатором таким образом, что пространственное расположение и ориентация гранул обеспечивают сопротивление движению реагентов и продуктов реакции, близкое к равному по объему отсеков для катализатора как при температуре и давлении во время протекания реакции синтеза метанола, так при температуре и давлении во время протекания реакции синтеза синтетической нефти; печи трубчатой риформинга; охладителя газа; подогревателя деаэрированной воды; подогревателя недеаэрированной воды; холодильника-конденсатора; рекуператора; аппаратов воздушного охлаждения; сепараторов; насосов; деаэратора щелевого; компрессорных агрегатов; сборника метанола или синтетической нефти; ресивера азота; емкостей; расширителя непрерывной продувки; ресивера воздуха КИП; мембранного блока; комплекса получения питательной воды; воздуходувки; дымососа; наружного оборудования. 2. Завод для производства метанола или синтетической нефти по п.1, отличающийся тем, что здание комплектуется из блоков-укрытий полной заводской готовности с системами отопления, освещения, пожарной сигнализации и полной технологической комплектации, а также из блока-укрытия ...

Подробнее
20-11-2008 дата публикации

РЕАКТОР ДЛЯ ПРОВЕДЕНИЯ ГЕТЕРОГЕННОГО ЭКЗОТЕРМИЧЕСКОГО ПРОЦЕССА

Номер: RU0000078094U1

1. Реактор для проведения гетерогенного экзотермического процесса, включающий вертикальный корпус, крышку и днище, штуцера для ввода исходной газовой смеси и вывода продуктов реакции, газопроницаемые горизонтальные перегородки, на которых расположены слои катализатора и, по крайней мере, одну камеру смешения для перемешивания горячего газового потока, выходящего из слоя катализатора, и холодного газового потока, поступающего через распределительное средство, соединенное со штуцером для ввода холодного газа, причем камера смешения выполнена с возможностью сообщения с промежуточным пространством, образованным между газопроницаемой перегородкой и соответствующей глухой перегородкой, установленной ниже и параллельно газопроницаемой перегородке, отличающийся тем, что он снабжен газоходом, установленным коаксиально камере смешения и оси реактора и выполненным в виде трубы, имеющей выход в объем реактора ниже глухой перегородки, при этом камера смешения герметично соединена с газопроницаемой перегородкой и частично погружена в слой катализатора. 2. Реактор по п.1, отличающийся тем, что камера смешения выполнена в виде полого цилиндра с глухими крышкой и днищем, причем на уровне промежуточного пространства в стенке камеры выполнены отверстия для поступления частично перемешанного в промежуточном пространстве газового потока. РОССИЙСКАЯ ФЕДЕРАЦИЯ (19) RU (11) 78 094 (13) U1 (51) МПК B01J 8/00 (2006.01) C07C 31/04 (2006.01) ФЕДЕРАЛЬНАЯ СЛУЖБА ПО ИНТЕЛЛЕКТУАЛЬНОЙ СОБСТВЕННОСТИ, ПАТЕНТАМ И ТОВАРНЫМ ЗНАКАМ (12) ОПИСАНИЕ ПОЛЕЗНОЙ МОДЕЛИ К ПАТЕНТУ (21), (22) Заявка: 2008123592/22 , 10.06.2008 (24) Дата начала отсчета срока действия патента: 10.06.2008 (45) Опубликовано: 20.11.2008 (73) Патентообладатель(и): Институт катализа им. Г.К. Борескова Сибирского отделения Российской академии наук (RU) Ñòðàíèöà: 1 U 1 7 8 0 9 4 R U U 1 Формула полезной модели 1. Реактор для проведения гетерогенного экзотермического процесса, включающий вертикальный корпус, крышку и днище, штуцера для ввода ...

Подробнее
10-09-2009 дата публикации

УСТАНОВКА ДЛЯ ПОЛУЧЕНИЯ МЕТАНОЛА

Номер: RU0000086590U1

Установка для получения метанола, содержащая установку комплексной подготовки газа, реактор для проведения газофазного окисления углеводородного газа, состоящий из теплообменника «газ-газ» реакционной зоны, набранного из единичных цилиндрических труб и теплообменника «газ-вода» зоны охлаждения, холодильник-конденсатор для окончательного охлаждения реакционной смеси и разделения отходящих газов и жидких продуктов, ректификационный узел для разделения метанола и других жидких продуктов и систему экологической очистки для очистки кубового остатка и отходящих газов, отличающаяся тем, что длина единичной обогреваемой цилиндрической трубы 820÷850 мм; внутренний диаметр единичной цилиндрической трубы 67÷69 мм; внутренняя поверхность единичной цилиндрической трубы отшлифована; для обогрева единичных цилиндрических труб реакционной зоны предусмотрена газовая горелка. РОССИЙСКАЯ ФЕДЕРАЦИЯ (19) RU (11) (13) 86 590 U1 (51) МПК C07C 29/48 (2006.01) C07C 31/04 (2006.01) B01J 19/24 (2006.01) ФЕДЕРАЛЬНАЯ СЛУЖБА ПО ИНТЕЛЛЕКТУАЛЬНОЙ СОБСТВЕННОСТИ, ПАТЕНТАМ И ТОВАРНЫМ ЗНАКАМ (12) ОПИСАНИЕ ПОЛЕЗНОЙ МОДЕЛИ К ПАТЕНТУ (21), (22) Заявка: 2009110951/22, 25.03.2009 (24) Дата начала отсчета срока действия патента: 25.03.2009 (45) Опубликовано: 10.09.2009 8 6 5 9 0 R U Формула полезной модели Установка для получения метанола, содержащая установку комплексной подготовки газа, реактор для проведения газофазного окисления углеводородного газа, состоящий из теплообменника «газ-газ» реакционной зоны, набранного из единичных цилиндрических труб и теплообменника «газ-вода» зоны охлаждения, холодильник-конденсатор для окончательного охлаждения реакционной смеси и разделения отходящих газов и жидких продуктов, ректификационный узел для разделения метанола и других жидких продуктов и систему экологической очистки для очистки кубового остатка и отходящих газов, отличающаяся тем, что длина единичной обогреваемой цилиндрической трубы 820÷850 мм; внутренний диаметр единичной цилиндрической трубы 67÷69 мм; ...

Подробнее
10-04-2010 дата публикации

УСТАНОВКА ДЛЯ ПРОИЗВОДСТВА МЕТАНОЛА

Номер: RU0000092859U1

Установка для производства метанола, содержащая устройство комплексной подготовки газа, реактор для проведения газофазного окисления углеводородного газа, состоящий из теплообменника «газ-газ» реакционной зоны, набранного из единичных цилиндрических труб и теплообменника «газ-вода» зоны охлаждения, холодильник-конденсатор, газовую горелку, ректификационный узел и систему экологической очистки, элементы установки, составляющие газожидкостный тракт, выполнены стальными, отличающаяся тем, что длина единичной обогреваемой цилиндрической трубы 800÷2000 мм; внутренний диаметр единичной цилиндрической трубы 60÷100 мм, а все внутренние поверхности этих элементов покрыты термически и химически стойкой эмалью. РОССИЙСКАЯ ФЕДЕРАЦИЯ (19) RU (11) 92 859 (13) U1 (51) МПК C07C 29/147 (2006.01) C07C 31/04 (2006.01) B01J 19/00 (2006.01) ФЕДЕРАЛЬНАЯ СЛУЖБА ПО ИНТЕЛЛЕКТУАЛЬНОЙ СОБСТВЕННОСТИ, ПАТЕНТАМ И ТОВАРНЫМ ЗНАКАМ (12) ОПИСАНИЕ ПОЛЕЗНОЙ МОДЕЛИ К ПАТЕНТУ (21), (22) Заявка: 2009148744/22, 28.12.2009 (24) Дата начала отсчета срока действия патента: 28.12.2009 (45) Опубликовано: 10.04.2010 9 2 8 5 9 R U Формула полезной модели Установка для производства метанола, содержащая устройство комплексной подготовки газа, реактор для проведения газофазного окисления углеводородного газа, состоящий из теплообменника «газ-газ» реакционной зоны, набранного из единичных цилиндрических труб и теплообменника «газ-вода» зоны охлаждения, холодильник-конденсатор, газовую горелку, ректификационный узел и систему экологической очистки, элементы установки, составляющие газожидкостный тракт, выполнены стальными, отличающаяся тем, что длина единичной обогреваемой цилиндрической трубы 800÷2000 мм; внутренний диаметр единичной цилиндрической трубы 60÷100 мм, а все внутренние поверхности этих элементов покрыты термически и химически стойкой эмалью. Ñòðàíèöà: 1 ru CL U 1 U 1 (54) УСТАНОВКА ДЛЯ ПРОИЗВОДСТВА МЕТАНОЛА 9 2 8 5 9 (73) Патентообладатель(и): Государственное образовательное учреждение высшего ...

Подробнее
10-12-2011 дата публикации

УСТАНОВКА ДЛЯ ПОЛУЧЕНИЯ МЕТАНОЛА

Номер: RU0000111133U1

Установка для получения метанола, содержащая установку комплексной подготовки газа, реактор для проведения газофазного окисления углеводородного газа, состоящий из теплообменника «газ-газ» реакционной зоны, набранного из единичных цилиндрических труб и теплообменника «газ-вода» зоны охлаждения, холодильник-конденсатор для окончательного охлаждения поступающей из зоны охлаждения реактора реакционной смеси и разделения отходящих газов и жидких продуктов, ректификационный узел для разделения поступающих из холодильника-конденсатора метанола и других жидких продуктов и систему экологической очистки для очистки поступающего из ректификационного узла кубового остатка и отходящих газов из холодильника-конденсатора, газовую горелку для обогрева единичных цилиндрических труб реакционной зоны, отличающаяся тем, что снабжена замкнутым контуром обогрева реакционной зоны реактора, включающим дымосос 14, теплообменник «газ-вода» 15 для съема излишков тепла, автоматический подогреватель воздуха 7 для обеспечения заданной температуры и расхода нагретого воздуха, а также - зарубашечное пространство реакционной зоны в виде теплообменника «газ-газ». РОССИЙСКАЯ ФЕДЕРАЦИЯ (19) RU (11) (13) 111 133 U1 (51) МПК C07C 29/48 (2006.01) C07C 31/04 (2006.01) ФЕДЕРАЛЬНАЯ СЛУЖБА ПО ИНТЕЛЛЕКТУАЛЬНОЙ СОБСТВЕННОСТИ (12) ОПИСАНИЕ (21)(22) Заявка: ПОЛЕЗНОЙ МОДЕЛИ К ПАТЕНТУ 2011111031/15, 23.03.2011 (24) Дата начала отсчета срока действия патента: 23.03.2011 (45) Опубликовано: 10.12.2011 Бюл. № 34 1 1 1 1 3 3 R U Формула полезной модели Установка для получения метанола, содержащая установку комплексной подготовки газа, реактор для проведения газофазного окисления углеводородного газа, состоящий из теплообменника «газ-газ» реакционной зоны, набранного из единичных цилиндрических труб и теплообменника «газ-вода» зоны охлаждения, холодильникконденсатор для окончательного охлаждения поступающей из зоны охлаждения реактора реакционной смеси и разделения отходящих газов и жидких продуктов, ректификационный ...

Подробнее
20-02-2012 дата публикации

ТЕХНОЛОГИЧЕСКАЯ ЛИНИЯ ОБЕЗВОЖИВАНИЯ БУТИЛОВЫХ СПИРТОВ

Номер: RU0000113520U1

1. Технологическая линия обезвоживания бутиловых спиртов, включающая систему подачи сырья, экстрактор с верхним и нижним входным отверстием, а также с верхним и нижним выходным отверстием, колонну регенерации и ректификационную колонну, причем верхнее выходное отверстие связано с колонной регенерации, верхняя часть которой соединена с нижним входным отверстием экстрактора, верхнее входное отверстие связано с системой подачи сырья, нижнее выходное отверстие соединено с ректификационной колонной, верх которой соединен с верхним входным отверстием экстрактора. 2. Технологическая линия по п.1, отличающаяся тем, что экстрактор представляет собой экстракционный аппарат с числом степеней контакта не менее одной. И 1 113520 ко РОССИЙСКАЯ ФЕДЕРАЦИЯ ВУ” 113 520°° 44 ФЕДЕРАЛЬНАЯ СЛУЖБА ПО ИНТЕЛЛЕКТУАЛЬНОЙ СОБСТВЕННОСТИ (12) ИЗВЕЩЕНИЯ К ПАТЕНТУ НА ПОЛЕЗНУЮ МОДЕЛЬ ММ9К Досрочное прекращение действия патента из-за неуплаты в установленный срок пошлины за поддержание патента в силе Дата прекращения действия патента: 20.07.2019 Дата внесения записи в Государственный реестр: 17.04.2020 Дата публикации и номер бюллетеня: 17.04.2020 Бюл. №11 Стр.: 1 па ОС‘ Ь ЕП

Подробнее
27-04-2012 дата публикации

УСТРОЙСТВО ДЛЯ ПОЛУЧЕНИЯ МЕТАНОЛА

Номер: RU0000115352U1

Устройство для получения метанола, содержащее установку комплексной подготовки газа, реактор для проведения газофазного окисления углеводородного газа, состоящий из теплообменника «газ-газ» реакционной зоны, набранного из единичных цилиндрических труб, и теплообменника «газ-вода» зоны охлаждения, холодильник-конденсатор для окончательного охлаждения реакционной смеси и разделения отходящих газов и жидких продуктов, ректификационный узел для разделения метанола и других жидких продуктов и систему экологической очистки кубового остатка и отходящих газов, в межтрубном герметическом пространстве теплообменника «газ-газ» реакционной зоны располагается рабочее вещество в виде расплава солей, имеющее температуру кипения 400-450°С, а само межтрубное пространство соединено с герметическим межтрубным пространством теплообменника «газ-газ», отличающееся тем, что герметическое межтрубное пространство теплообменника «газ-газ» соединено с устройством регулировки давления. РОССИЙСКАЯ ФЕДЕРАЦИЯ (19) RU (11) (13) 115 352 U1 (51) МПК C07C 29/48 (2006.01) C07C 31/04 (2006.01) B01J 19/24 (2006.01) ФЕДЕРАЛЬНАЯ СЛУЖБА ПО ИНТЕЛЛЕКТУАЛЬНОЙ СОБСТВЕННОСТИ (12) ОПИСАНИЕ (21)(22) Заявка: ПОЛЕЗНОЙ МОДЕЛИ К ПАТЕНТУ 2011148219/04, 25.11.2011 (24) Дата начала отсчета срока действия патента: 25.11.2011 (45) Опубликовано: 27.04.2012 Бюл. № 12 (73) Патентообладатель(и): Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Пензенский государственный университет" (ФГБОУ ВПО "Пензенский государственный университет") (RU) 1 1 5 3 5 2 R U Формула полезной модели Устройство для получения метанола, содержащее установку комплексной подготовки газа, реактор для проведения газофазного окисления углеводородного газа, состоящий из теплообменника «газ-газ» реакционной зоны, набранного из единичных цилиндрических труб, и теплообменника «газ-вода» зоны охлаждения, холодильникконденсатор для окончательного охлаждения реакционной смеси и разделения отходящих газов и ...

Подробнее
20-08-2013 дата публикации

УСТАНОВКА ПОЛУЧЕНИЯ ТРЕТИЧНОГО БУТИЛОВОГО СПИРТА

Номер: RU0000131378U1
Автор:

Установка получения третичного бутилового спирта жидкофазной реакцией изобутиленсодержащей углеводородной смеси с водой при повышенной температуре в присутствии третичного бутилового спирта в качестве растворителя, включающая 4-полочный реактор, заполненный сульфокатионитным катализатором и блок ректификации полученной реакционной смеси, отличающаяся тем, что установка состоит из трех реакторов, из которых два параллельно работающие 4-полочные реакторы с одинаковым количеством загруженного в них сульфокатионитного катализатора, и отдельно стоящего от них 4-секционного реактора с одинаковой загрузкой того же сульфокатионитного катализатора по секциям, в который общим потоком поступает реакционная смесь из предыдущих двух 4-полочных реакторов. РОССИЙСКАЯ ФЕДЕРАЦИЯ (19) RU (11) (13) 131 378 U1 (51) МПК C07C 31/12 (2006.01) C07C 29/04 (2006.01) ФЕДЕРАЛЬНАЯ СЛУЖБА ПО ИНТЕЛЛЕКТУАЛЬНОЙ СОБСТВЕННОСТИ (12) ОПИСАНИЕ (21)(22) Заявка: ПОЛЕЗНОЙ МОДЕЛИ К ПАТЕНТУ 2012155076/04, 25.02.2013 (24) Дата начала отсчета срока действия патента: 25.02.2013 (73) Патентообладатель(и): Общество с ограниченной ответственностью "Научно-производственное объединение ЕВРОХИМ" (RU) R U Приоритет(ы): (22) Дата подачи заявки: 25.02.2013 (45) Опубликовано: 20.08.2013 Бюл. № 23 Адрес для переписки: 195267, Санкт-Петербург, а/я 39, Гец С.В. U 1 1 3 1 3 7 8 R U Стр.: 1 U 1 Формула полезной модели Установка получения третичного бутилового спирта жидкофазной реакцией изобутиленсодержащей углеводородной смеси с водой при повышенной температуре в присутствии третичного бутилового спирта в качестве растворителя, включающая 4-полочный реактор, заполненный сульфокатионитным катализатором и блок ректификации полученной реакционной смеси, отличающаяся тем, что установка состоит из трех реакторов, из которых два параллельно работающие 4-полочные реакторы с одинаковым количеством загруженного в них сульфокатионитного катализатора, и отдельно стоящего от них 4-секционного реактора с одинаковой загрузкой того же ...

Подробнее
05-01-2012 дата публикации

Process for the catalytic halogenation of a diol

Номер: US20120004432A1
Принадлежит: Akzo Nobel NV

The present invention relates to a process for the catalytic halogenation of an organic compound comprising at least one vicinal diol moiety, said process comprising a step of bringing the organic compound comprising at least one vicinal diol moiety into contact with a hydrogen halide in the presence of a catalyst, characterized in that the catalyst is an organic compound comprising a β-diketone moiety or a β-keto aldehyde moiety.

Подробнее
10-12-2016 дата публикации

КОЛОННА ОКОНЧАТЕЛЬНОЙ ОЧИСТКИ С КОМБИНИРОВАННОЙ ТЕРМОКОМПРЕССОРНОЙ УСТАНОВКОЙ

Номер: RU0000166869U1

РОССИЙСКАЯ ФЕДЕРАЦИЯ (19) RU (11) (13) 166 869 U1 (51) МПК B01D 3/14 (2006.01) C07C 31/08 (2006.01) ФЕДЕРАЛЬНАЯ СЛУЖБА ПО ИНТЕЛЛЕКТУАЛЬНОЙ СОБСТВЕННОСТИ (12) ОПИСАНИЕ (21)(22) Заявка: ПОЛЕЗНОЙ МОДЕЛИ К ПАТЕНТУ 2016118494/05, 12.05.2016 (24) Дата начала отсчета срока действия патента: 12.05.2016 (45) Опубликовано: 10.12.2016 U 1 1 6 6 8 6 9 R U Стр.: 1 U 1 (54) КОЛОННА ОКОНЧАТЕЛЬНОЙ ОЧИСТКИ С КОМБИНИРОВАННОЙ ТЕРМОКОМПРЕССОРНОЙ УСТАНОВКОЙ (57) Реферат: Полезная модель относится к области безмаслянный компрессор и струйный аппарат, производства пищевого этанола и может быть новым является то, что патрубок для отбора пара применена для сокращения энергозатрат на из верхней части колонны одним паропроводом обогрев колонны окончательной очистки или последовательно соединен сначала с других ректификационных колонн с небольшим механическим компрессором и затем соплом высотным перепадом температур. эжектора, а другим паропроводом со Технической задачей полезной модели всасывающей камерой эжектора, который далее является повышение эффективности соединен паропроводом с дефлегматоромиспользования тепловой энергии вторичных испарителем, нижняя часть которого имеет для энергоресурсов ректификационной установки отбора конденсата патрубок, соединенный путем реализации надёжного способа снижения трубопроводом для подачи конденсата насосом энергозатрат на обогрев колонны окончательной в верхнюю часть колонны для ее орошения, при очистки, позволяющего применить в схеме для этом кубовая часть колонны снабжена патрубком обогрева колонны стандартизованное, для отбора очищенного этанола. выпускаемое промышленностью оборудование. Колонна окончательной очистки с Техническая задача полезной модели комбинированной термокомпрессорной достигается тем, что в колонне окончательной установкой позволяет снизить затраты греющего очистки с комбинированной термокомпрессорной пара на 0,7 - 1,0 кг/кг абсолютного этанола, установкой, содержащей механический отличается простотой и управляемостью. 1 ил. 1 ...

Подробнее
27-12-2018 дата публикации

КОМБИНИРОВАННЫЙ РЕАКТОР ДЛЯ ПРОИЗВОДСТВА ОКСИГЕНАТОВ И ЖИДКИХ УГЛЕВОДОРОДОВ ИЗ СИНТЕЗ-ГАЗА

Номер: RU0000186042U1

Полезная модель относится к области органического синтеза, в частности к производству оксигенатов (метанола, ДМЭ) и углеводородов бензинового ряда (бензина и ароматических углеводородов) из синтез-газа, получаемого путем конверсии углеродсодержащего сырья. Целью полезной модели является переработка синтез газа в жидкие углеводороды на одном комбинированном реакторе через стадию получения оксигенатов на смесевых катализаторах с возможностью параллельной регенерации цеолитсодержащего катализатора. Поставленная задача достигается тем, что комбинированный реактор представляет собой двухсекционный сосуд с глухой тарелкой, разделяющей его на две части: первая верхняя часть заполнена смесью для синтеза оксигенатов, а вторая нижняя - катализатором для конверсии оксигенатов в жидкие углеводороды, при этом сырье поступает из верхней секции в нижнюю через переливное устройство, в котором, при необходимости, нагревается в выносном секционном аппарате, затем продукция поступает в нижнюю секцию, после чего отводится для сепарации и подготовки, при этом регенерация второй секции осуществляется путем отведения продукции первой ступени для накопления или во вспомогательный реактор на время регенерации второй секции смесью азота и кислорода. И 1 186042 ко РОССИЙСКАЯ ФЕДЕРАЦИЯ ВУ” 186 042” 44 ФЕДЕРАЛЬНАЯ СЛУЖБА ПО ИНТЕЛЛЕКТУАЛЬНОЙ СОБСТВЕННОСТИ (12) ИЗВЕЩЕНИЯ К ПАТЕНТУ НА ПОЛЕЗНУЮ МОДЕЛЬ ММ9К Досрочное прекращение действия патента из-за неуплаты в установленный срок пошлины за поддержание патента в силе Дата прекращения действия патента: 08.10.2018 Дата внесения записи в Государственный реестр: 18.12.2019 Дата публикации и номер бюллетеня: 18.12.2019 Бюл. №35 Стр.: 1 па СУОЭЗЬ ЕП

Подробнее
21-05-2021 дата публикации

Автоматический компактный бытовой дистиллятор для производства этилового спирта

Номер: RU0000204375U1

Полезная модель относится к области техники и технологий, предназначенных для разделения и рафинирования жидких многокомпонентных спиртосодержащих смесей в бытовых условиях и предусматривающих нагрев до температуры испарения, последующую перегонку и конденсацию перебродившего пищевого сырья и получение раствора этилового спирта в качестве конечного продукта. Устройство содержит последовательно соединенные с помощью трубок перегонный куб, включающий в себя теплоизолированный металлический корпус произвольной формы, высокочастотный индукционный источник тепла, датчики системы безопасности и крышку, сухопарник, включающий в себя теплоизолированный металлический корпус произвольной формы и объёма, соответствующую крышку, патрубки подвода и отвода паров спирта, датчики системы безопасности, змеевик, охладитель, включающий в себя корпус произвольной формы и объёма, соответствующую крышку, комбинированную систему охлаждения, основанную на использовании элементов Пельтье, патрубки подвода и отвода паров спирта, циркуляции жидкого конечного продукта, микропроцессорную систему управления, основанную на использовании ARM-модуля управления. Техническим результатом является обеспечение безопасного, полностью автоматизированного и удобного для конечного пользователя получение высококачественного раствора этилового спирта. Достигается технический результат за счет применения облачных технологий и микропроцессорного управления, использования комплексной системы охлаждения, применения эффективных теплоизоляционных материалов и индукционного источника тепла. РОССИЙСКАЯ ФЕДЕРАЦИЯ (19) RU (11) (13) 204 375 U1 (51) МПК B01D 3/02 (2006.01) B01D 3/42 (2006.01) C07C 31/08 (2006.01) ФЕДЕРАЛЬНАЯ СЛУЖБА ПО ИНТЕЛЛЕКТУАЛЬНОЙ СОБСТВЕННОСТИ (12) ОПИСАНИЕ ПОЛЕЗНОЙ МОДЕЛИ К ПАТЕНТУ (52) СПК B01D 3/02 (2021.02); B01D 3/42 (2021.02) (21)(22) Заявка: 2021102082, 29.01.2021 (24) Дата начала отсчета срока действия патента: Дата регистрации: 21.05.2021 (45) Опубликовано: 21.05.2021 Бюл. № 15 2 0 4 3 7 5 ...

Подробнее
26-01-2012 дата публикации

Fluorine-containing n-alkylsulfonylimide compound, manufacturing method therefor, and method of manufacturing an ionic compound

Номер: US20120022269A1

According to the method for producing fluorine-containing N-alkylsulfonylimide compound, the fluorine-containing N-alkylsulfonylimide compound can be produced safely with a high recovery rate by alkylating fluorine-containing sulfonylimide acid or fluorine-containing sulfonylimide acid salt with dialkylsulfuric acid or dialkylcarbonic acid.

Подробнее
23-02-2012 дата публикации

Process for preparing organic compounds by a transition metal-catalysed cross-coupling reaction of an aryl-x, heteroaryl-x, cycloalkenyl-x or alkenyl-x compound with an alkyl, alkenyl, cycloalkyl or cycloalkenyl halide

Номер: US20120046471A1
Принадлежит: Saltigo GmbH

This invention relates to a process for preparing functionalized aryl, heteroaryl, cycloalkenyl, or alkenyl compounds, by a transition-metal-catalyzed cross-coupling reaction of a substituted or unsubstituted aryl-X, heteroaryl-X, cycloalkenyl-X or alkenyl-X compound with an alkyl, alkenyl, cycloalkyl or cycloalkenyl halide, where X is a halide, diazonium, tosylate (p-toluenesulphonate), mesylate (methanesulphonate) or triflate (trifluoromethanesulphonate) leaving group.

Подробнее
01-03-2012 дата публикации

(R)-(-)-1,2-propanediol compositions and methods

Номер: US20120053152A1
Автор: Edward T. Wei
Принадлежит: Individual

Short-chain 2- to 3-carbon alcohols are used as solvents for cooling agents in the preparation of topical therapeutic and cosmetic formulations. Some of these alcohols, especially ethanol, inhibit the ability of the cooling agent to activate its target receptor. In one embodiment of this invention, (R)-1,2-propanediol is used as an alcoholic solvent for the topical delivery of cooling agents to biological surfaces. This propanediol enantiomer has a minimum inhibitory effect on cooling with respect to standard 2- to 3-carbon alcoholic solvents, and functions to substantially protect the agent's cooling activity from inhibition when in the presence of a short-chain alcohol.

Подробнее
22-03-2012 дата публикации

Liquid agricultural formulations of improved stability

Номер: US20120071320A1
Принадлежит: DOW AGROSCIENCES LLC

Agricultural oil dispersions of improved stability and processes to make and methods to use such compositions are disclosed. The compositions are comprised of an active ingredient coated with one or more non-oil soluble polymers that hinder degradation of the active ingredient by other ingredients.

Подробнее
29-03-2012 дата публикации

Process for the preparation of cilastatin and sodium salt

Номер: US20120078009A1

An improved process for preparing Cilastatin Sodium including dissolving Cilastatin acid in a solvent using an organic base, adding sodium salt of a week acid and isolating Cilastatin Sodium.

Подробнее
05-04-2012 дата публикации

Novel Compounds, Pharmaceutical Compositions Containing Same, Methods of Use for Same, and Methods for Preparing Same

Номер: US20120083471A1
Принадлежит: JOHNS HOPKINS UNIVERSITY

The present invention relates to novel pharmaceutical compositions containing the same, and methods of use for a variety of therapeutically valuable uses including, but not limited to, treating obesity by inhibiting the activity of Glycerol 3-phosphate acyltransferase (GPAT).

Подробнее
17-05-2012 дата публикации

Libraries of n-substituted-n-phenylethylsulfonamides for drug discovery

Номер: US20120122920A1

New compounds are continually being sought for the treatment and prevention of disorders. The invention relates to N-substituted-N-phenylethylsulfonamides libraries which can be used in the search for, and identification of, new lead compounds that could modulate the functional activity of a biological target.

Подробнее
21-06-2012 дата публикации

Methods for Preparing Diaryl Disulfides

Номер: US20120157716A1
Принадлежит: UBE Industries Ltd

New and useful methods for preparing bulky diaryl disulfides from a benzene derivative and sulfur halide are disclosed.

Подробнее
28-06-2012 дата публикации

Methods for producing bis(sulfonyl)imide ammonium salt, bis(sulfonyl)imide and bis(sulfonyl)imide lithium salt

Номер: US20120165571A1
Принадлежит: Asahi Glass Co Ltd

To provide methods for producing a bis(sulfonyl)imide ammonium salt, a bis(sulfonyl)imide and a bis(sulfonyl)imide lithium salt simply and in good yield. A method for producing a bis(sulfonyl)imide ammonium salt, which comprises reacting a compound of the formula R—CHF—SO 2 X (wherein R is a C 1-4 fluorinated alkyl group which may contain an etheric oxygen atom, or a fluorine atom, and X is a fluorine atom or a chlorine atom) with ammonia in the absence of a catalyst. Further, methods for producing a bis(sulfonyl)imide and a bis(sulfonyl)imide lithium salt by using the bis(sulfonyl)imide ammonium salt.

Подробнее
28-06-2012 дата публикации

Process for preparing methylmercaptopropionaldehyde

Номер: US20120165573A1
Принадлежит: EVONIK DEGUSSA GmbH

A process for preparing methylmercaptopropionaldehyde in a single reaction unit, is provided. According to the preferred embodiment, the process comprises, simultaneously contacting a gaseous mixture comprising acrolein with a liquid mixture comprising methylmercaptopropionaldehyde, methyl mercaptan, a catalyst and methylmercaptopropionaldehyde methyl thiohemiacetal in the reactive absorber; absorbing the acrolein from the gaseous mixture into the liquid mixture; reacting the absorbed acrolein with the methyl mercaptan or the methylmercaptopropionaldehyde methyl thiohemiacetal to obtain methylmercapto-propionaldehyde; removing gaseous impurities and by-products from the liquid mixture; and separating the obtained methylmercaptopropionaldehyde product from the reactive absorber, directing a portion of the separated product to storage or further processing and recycling the remaining portion to the reactive absorber; wherein the methyl mercaptan optionally comprises dimethyl sulfide or dimethyl ether.

Подробнее
19-07-2012 дата публикации

Use of optionally oxidized thioethers of polyalkylene oxides in washing and cleaning compositions

Номер: US20120184478A1
Принадлежит: BASF SE

The present invention relates to the use of (oxidized) thioethers of polyalkylene oxides in washing and cleaning compositions, especially in dishwashing compositions, and to washing and cleaning compositions, especially dishwashing compositions, which comprise (oxidized) thioethers of alcohol alkoxylates. These (oxidized) thioethers are especially suitable as surfactants with rinse aid function (rinse aid surfactants). “Oxidized” relates to the sulfur atom in the thioether, which may be present in oxidized form as sulfoxide (SO) or sulfonyl (SO 2 ). The invention also relates to particular oxidized thioethers of polyalkylene oxides.

Подробнее
19-07-2012 дата публикации

Use of optionally oxidized thioethers of alcohol alkoxylates in washing and cleaning compositions

Номер: US20120184479A1
Принадлежит: BASF SE

The present invention relates to the use of (oxidized) thioethers of alcohol alkoxylates in washing and cleaning compositions, especially in dishwashing compositions, and to washing and cleaning compositions, especially dishwashing compositions, which comprise (oxidized) thioethers of alcohol alkoxylates. These (oxidized) thioethers are especially suitable as surfactants with rinse aid function (rinse aid surfactants). “Oxidized” relates to the sulfur atom in the thioether, which may be present in oxidized form as sulfoxide (SO) or sulfonyl (SO 2 ).

Подробнее
27-09-2012 дата публикации

Method for producing n-acylamino acid

Номер: US20120245381A1
Автор: Toshiaki Suzuki
Принадлежит: Sumitomo Chemical Co Ltd

There is provided a method for producing N-acylamino acid of formula (I): wherein R 1 , R 2 and R 3 are the same or different and each independently represents a hydrogen atom, a substituted or unsubstituted hydrocarbyl group, or a substituted or unsubstituted heterocyclic group, which comprises supplying an aldehyde compound of formula (II): wherein R 1 is as defined above, an amide compound of formula (III): wherein R 2 and R 3 are as defined above, and a solvent to a reactor in which a solvent, a palladium compound, a halide compound, and carbon monoxide had been charged.

Подробнее
29-11-2012 дата публикации

Herbicidal mixtures

Номер: US20120302441A1
Принадлежит: BASF SE

A synergistic herbicidal mixture comprising A) picolinafen; or one of its environmentally compatible salts; and B) a synergistically effective amount of at least a sulfonylurea of formula II wherein the variables A, B, X and R 1 to R 3 have the meanings given in the specification; and, if desired, C) at least a safener. Compositions comprising these mixtures, processes for the preparation of these compositions and their use for controlling undesired plants.

Подробнее
27-12-2012 дата публикации

Benzopinacol metalloester polymerization initiator

Номер: US20120329967A1
Принадлежит: Elantas PDG Inc

A polymerization initiator based on boroesters of benzopinacol for curing unsaturated polymers is disclosed. Methods of preparing the benzopinacol boroester initiator and using the initiator in polymerization reactions are additionally disclosed.

Подробнее
27-12-2012 дата публикации

Method for preparing acrolein from glycerol or glycerine

Номер: US20120330049A1

The invention relates to a method for preparing acrolein from glycerol or glycerin, according to which dehydration of glycerol or glycerin is carried out in the presence of a catalyst which consists in at least one silica modified with zirconium dioxide, titanium dioxide or tungsten trioxide or any combination of these oxides, and a heteropolyacid. This method may be used for making 3-(methylthio)propionic aldehyde (MMP), 2-hydroxy-4-methylthiobutyronitrile (HMBTN), methionine or its analogs, from acrolein.

Подробнее
14-03-2013 дата публикации

Method for manufacturing fluorine-containing imide compound

Номер: US20130066110A1
Принадлежит: Mitsubishi Materials Corp

With this method for manufacturing fluorine-containing imide compounds, a method for manufacturing a fluorine-containing imide compound ((Rf 1 SO 2 )(Rf 2 SO 2 )NH) is selected which includes reaction of a fluorine-containing sulfonic acid (Rf 1 SO 3 H) and a fluorine-containing sulfonamide (Rf 2 SO 2 NH) in the presence of thionyl chloride. Wherein, Rf 1 and Rf 2 are fluorine, or straight-chain or branched perfluoroalkyl groups with a carbon number of 1-4.

Подробнее
14-03-2013 дата публикации

Process for Enantioselective Synthesis of Single Enantiomers of Modafinil by Asymmetric Oxidation

Номер: US20130066111A1
Принадлежит: CEPHALON FRANCE

The invention relates to a method for preparing a sulphoxide compound of formula (I) either as a single enantiomer or in an enantiomerically enriched form, comprising the steps of: 1. A three-step method for preparing enantiomerically enriched modafinil , wherein the steps comprise:a) dissolving non-racemic modafinil in a solvent to form a solution;b) crystallizing a modafinil enantiomer from the solution; andc) isolating the crystallized modafinil enantiomer, wherein the isolated modafinil enantiomer has an enantiomeric excess at least about 3% higher than the non-racemic modafinil dissolved in step (a).2. The method of claim 1 , wherein the solvent comprises ethanol claim 1 , tetrahydrofuran claim 1 , acetone claim 1 , dichloromethane claim 1 , acetonitrile claim 1 , or ethyl acetate.3. The method of claim 2 , wherein the solvent comprises ethanol.4. The method of claim 2 , wherein the solvent comprises tetrahydrofuran claim 2 , acetone claim 2 , dichloromethane claim 2 , acetonitrile claim 2 , or ethyl acetate.5. The method of claim 4 , wherein the solvent comprises tetrahydrofuran.6. The method of claim 5 , wherein the solvent comprises a mixture of tetrahydrofuran and water.7. The method of claim 6 , wherein the solvent comprises a mixture of about 95/5 tetrahydrofuran/water.8. The method of claim 4 , wherein the solvent comprises dichloromethane.9. The method of claim 4 , wherein the solvent comprises acetonitrile.10. The method of claim 4 , wherein the solvent comprises ethyl acetate.11. The method of claim 10 , wherein the solvent comprises a mixture of ethyl acetate and methanol.12. The method of claim 11 , wherein the solvent comprises a mixture of about 6/1 ethyl acetate/methanol.13. The method of claim 4 , wherein the solvent comprises acetone.14. The method of claim 13 , wherein the solvent comprises a mixture of acetone and water.15. The method of claim 14 , wherein the solvent comprises a mixture of about 95/5 acetone/water.16. The method of claim 1 , ...

Подробнее
14-03-2013 дата публикации

INSECTICIDE FOR AGRICULTURAL OR HORTICULTURAL USE AND METHOD OF USE THEREOF

Номер: US20130066114A1
Принадлежит: Mitsui Chemicals, Inc.

Aniline derivatives represented by formula (8): 121-. (canceled) The present invention relates to compounds represented by formula (1), insecticides containing the compounds as active ingredients, a method for producing the insecticides, and a method for using the insecticides.PCT Japanese Translation Patent Publication No. 11-511442 discloses salicylic compounds similar to compounds of the present invention. However, compounds represented by formula (1) of the present invention do not have a salicylic skeleton, and the compounds disclosed in the above publication are clearly outside the scope of claims of the present invention.Publication No. WO2003-22806 discloses compounds as production intermediates similar to the compounds of the present invention, but it does not disclose an activity to insects. Also, the compounds disclosed in the publication are clearly outside the scope of claims of the present invention.J. Org. Chem. 142 (1966) discloses compounds as production intermediates similar to the compounds of the present invention, but it does not disclose an activity to insects. Also, the compounds disclosed in the publication are clearly outside the scope of claims of the present invention.J. Am. Chem. Soc. 6382 (2000) discloses compounds as production intermediates similar to the compounds of the present invention, but it does not disclose an activity to insects. Also, the compounds disclosed in the publication are clearly outside the scope of claims of the present invention.An object of the present invention is to provide insecticides having high effectiveness.As a result of intensive research for achieving the object, the inventors found that the compounds of the present invention are novel compounds not disclosed in any document and have an excellent insecticidal effect, and the compounds can be used as new insecticides. It is also found that intermediates in production of the compounds of the present invention are not disclosed in any document and are ...

Подробнее
21-03-2013 дата публикации

Methods and Compounds Regulating the Erythroid Response to Iron Deficiency

Номер: US20130072428A1

The present invention discloses the signaling pathway involved erythroid repression by iron deficiency. Further disclosed is anon-toxic small-molecule compound which potently reverses the erythroid repression caused by iron deficiency. The present invention further encompasses novel compounds for inhibition of red cell production, useful, for example, in the treatment of polycythemia vera, a malignancy causing uncontrolled red cell production. These inhibitory compounds also promote megakaryocytic lineage commitment and may therefore be useful for augmentation of platelet production. The present invention further discloses isocitrate reversal of iron deprivation. 1. A composition for treating iron deficiency , comprising an effective amount of isocitrate or a derivative thereof , and at least one pharmaceutically acceptable carrier , diluent , or excipient.2. The composition of claim 1 , further comprising erythropoietin.3. A method of treating iron deficiency comprising administering to a subject in need thereof a composition comprising a therapeutically effective amount of isocitrate or a derivative thereof claim 1 , and at least one pharmaceutically acceptable carrier claim 1 , diluent claim 1 , or excipient.4. The method of claim 3 , wherein said composition further comprises erythropoietin.5. The method of claim 3 , wherein the production of red blood cells is stimulated.6. The method of claim 3 , wherein megakaryopoiesis and platelet production is decreased.7. The method of claim 3 , wherein said composition is administered daily.8. The method of claim 3 , wherein the administration is intravenous.9. The method of claim 3 , wherein the administration is intramuscular.10. The method of claim 3 , wherein said subject has anemia of inflammation.11. The method of claim 3 , wherein said subject has anemia of chronic kidney disease.12. The method of claim 3 , wherein said subject is elderly.13. A composition fur decreasing red blood cell production claim 3 , ...

Подробнее
21-03-2013 дата публикации

ANTI-DIABETIC COMPOSTIONS AND METHODS

Номер: US20130072454A1
Принадлежит: OZSTAR THERAPEUTICS PTY LTD

The present invention is concerned with synergistic compositions effective in the treatment of diabetes. In particular, the present invention is concerned with synergistic compositions comprising inulin, or a suitable source thereof, and Sulphonylureas used in the treatment of type-2 Diabetes Mellitus (T2DM) and hyperglyacemia. 1. Method of treating diabetes comprising the administration to a subject requiring such treatment of a composition comprising inulin , or a source thereof , and a sulphonylurea , in the amount and for a time sufficient to reduce , regulate or normalize blood glucose concentration.2. Method of improving efficacy of sulphonylurea treatment of diabetes in a subject receiving a sulphonylurea anti-diabetic therapy , comprising administration to said subject , a composition comprising inulin or a source thereof.3. A method of or , wherein diabetes is Type-2 diabetes mellitus.4. Method of treating hyperglycemia comprising the administration to a subject requiring such treatment of a composition comprising inulin , or a source thereof , and a sulphonylurea , in the amount and for a time sufficient to reduce , regulate or normalize blood glucose concentration.5. Method of preventing the development of , or ameliorating , hypoglycaemia in a subject treated with a sulphonylurea , comprising the administration to a subject requiring such treatment of a composition comprising inulin or a source of inulin , in the amount and for a time sufficient to prevent or ameliorate hypoglycemia.6. A method of any one of to , wherein inulin , or a source thereof , is administered simultaneously or sequentially , in any order , with the sulphonylurea.7. A method of any one of to , wherein the source of inulin is a plant or part thereof.8. A method of claim 7 , wherein the plant or part thereof is selected from onion claim 7 , leek claim 7 , garlic claim 7 , artichoke claim 7 , salsify claim 7 , agave and chicory.9. A method according to claim 8 , wherein the source of ...

Подробнее
21-03-2013 дата публикации

PERACID AND 2-HYDROXY ORGANIC ACID COMPOSITIONS AND METHODS FOR SANITATION AND DISEASE PREVENTION

Номер: US20130072563A1
Автор: Ho Kai Lai Grace
Принадлежит: Fresh Express Incorporated

Methods and compositions for treating living surfaces to control microorganisms are provided. The method treats produce by contacting a living surface with an aqueous solution comprising i) an organic peracid of the formula RC(O)OOH wherein R is methyl, ethyl, n-propyl, or s-propyl; ii) a 2-hydroxy organic acid selected from tartaric acid, citric acid, malic acid, mandelic acid, and lactic acid; and iii) water. 1. A method of treating skin or mucosa comprising contacting the surface with an aqueous composition which comprises:i) an organic peracid of the formula RC(O)OOH wherein R is methyl, ethyl, n-propyl, or s-propyl;ii) a 2-hydroxy organic acid selected from tartaric acid, citric acid, malic acid, mandelic acid, and lactic acid; and, optionally, a surfactant;wherein the aqueous composition has a pH from 2.5 to 7.8, inclusive and the concentration of peracid is from 40 to 250 ppm (w/w) inclusive, and the concentration of the 2-hydroxy organic acid is from 0.1 to 1% (w/w), inclusive.2. The method of claim 1 , wherein the composition also comprises an anionic surfactant.3. The method of claim 1 , wherein the peracid is peroxyacetic acid and the 2-hydroxy organic acid is L-(+)-lactic acid.4. The method of claim 3 , wherein the concentration of the peroxyacetic acid in the composition is from 50 to 100 ppm (w/w) claim 3 , the concentration of the lactic acid in the composition is from 0.1% to 0.6% (w/w).5. The method of claim 3 , wherein concentration of peroxyacetic acid in the composition is from 60 to 80 ppm (w/w) claim 3 , the concentration of lactic acid in the composition is from 0.1% to 0.4% (w/w).6. The method of claim 3 , wherein the pH is between 2.5 and 4.5.7. The method of claim 1 , wherein the pH is from 2.8 to 3.2.8. The method of claim 1 , wherein the pH is about 3.0.9. The method of claim 1 , wherein the composition is at a temperature of 35° F. to 45° F.10. The method of claim 1 , wherein the composition is substantially free of nonionic surfactants ...

Подробнее
21-03-2013 дата публикации

Method for producing methionine

Номер: US20130072713A1
Автор: Kazuyasu Tani, Koji Hagiya
Принадлежит: Sumitomo Chemical Co Ltd

A novel method for producing methionine without using hydrogen cyanide as a raw material has been demanded. A method for producing methionine including a step A of oxidizing 4-methylthio-2-oxo-1-butanal in the presence of an alcohol; a step B of hydrolyzing a 4-methylthio-2-oxo-butanoic acid ester obtained in the step A; and a step C of subjecting 4-methylthio-2-oxo-butanoic acid obtained in the step B to reductive amination.

Подробнее
28-03-2013 дата публикации

PROCESSING BIOMASS

Номер: US20130078696A1
Принадлежит: XYLCEO INC.

Carbon-containing materials, such as biomass (e.g., plant biomass, animal biomass, and municipal waste biomass) or coal are processed to produce useful products, such as fuels. For example, systems are described that can use feedstock materials, such as cellulosic and/or lignocellulosic materials and/or starchy materials, to produce ethanol. 1. A method of making a product , comprising:modifying a manufacturing facility that was built to produce ethanol exclusively from grain, or from corn sweetener, sucrose, or lactose by adding a lignocellulosic saccharification unit to the facility;further modifying the manufacturing facility by adding electron beam irradiation equipment to the manufacturing facility;transporting a lignocellulosic starting material to the modified manufacturing facility;irradiating the lignocellulosic starting material by exposure to irradiation from the electron beam irradiation equipment, and irradiating the material with at least 10 Mrad of radiation, thereby producing an irradiated lignocellulosic material, wherein the irradiated lignocellulosic material has a lower level of recalcitrance than the lignocellulosic starting material;converting the irradiated lignocellulosic material to a product by utilizing the lignocellulosic saccharification unit; thereby producing a product.2. The method of wherein the lignocellulosic material is selected from the group consisting of paper claim 1 , paper products claim 1 , wood claim 1 , wood-related materials claim 1 , grasses claim 1 , rice hulls claim 1 , bagasse claim 1 , jute claim 1 , hemp claim 1 , flax claim 1 , bamboo claim 1 , sisal claim 1 , abaca claim 1 , straw claim 1 , corn cobs claim 1 , coconut hair claim 1 , industrial waste claim 1 , processing waste claim 1 , human waste claim 1 , and animal waste.3. The method of wherein the lignocellulosic material has been physically treated.4. The method of wherein the product comprises energy claim 1 , a fuel claim 1 , a food or a material.5. The ...

Подробнее
28-03-2013 дата публикации

Thiol-Selective Water-Soluble Polymer Derivatives

Номер: US20130079555A1
Принадлежит: Nektar Therapeutics

The present invention provides water-soluble, polymer derivatives having a thiol-selective terminus suitable for selective coupling to thiol groups, such as those contained in the cysteine residues of proteins, as well as methods for preparing the water-soluble, polymer derivatives having a thiol-selective terminus. 1. A method for a preparing a conjugate , said method comprising:reacting a water-soluble polymer comprising a water-soluble polymer segment (“POLY”) having one terminus activated with an electrophile (“-E”) with a molecule of the structure “NU—Y—S, comprising a nucleophile (“—NU”) and a maleimide (“—S”), and a linear group (“—Y—”) interposed between NU and S, under conditions effective to promote reaction between said electrophile and said nucleophile to form a polymer product comprising a maleimide (“POLY-S”),wherein the molecular mass of the water-soluble polymer segment is from 1,000 Daltons to 50,000 Daltons; andreacting the polymer product comprising a maleimide with a biologically active agent comprising a thiol group, to thereby result in a conjugate.2. The method of claim 1 , wherein said water-soluble polymer segment is selected from the group consisting of poly(alkylene oxide) claim 1 , poly(vinyl pyrrolidone) claim 1 , poly(vinyl alcohol) claim 1 , polyoxazoline claim 1 , poly(acryloylmorpholine) claim 1 , and poly(oxyethylated polyol).3. The method of claim 1 , wherein the POLY-S product comprises greater than about 95% by weight mono-functionally substituted POLY-S.4. The method of claim 1 , wherein the POLY-S product comprises less than about 5% di-functionally-substituted POLY-S.5. The method of claim 2 , wherein the water-soluble polymer segment is a polyalkylene oxide.6. The method of claim 5 , wherein said-water soluble polymer segment is a polyethylene glycol (PEG).7. The method of claim 6 , wherein said polyethylene glycol is end-capped.8. The method of claim 1 , wherein said electrophile is a carboxylic acid or a carboxylic acid ...

Подробнее
04-04-2013 дата публикации

Herbicidal composition

Номер: US20130085065A1
Принадлежит: Ishihara Sangyo Kaisha Ltd

At present, many herbicidal compositions have been developed and used, but there are a variety of types of weeds to be controlled, and their development lasts for a long period of time. Thus, a high active and long-residual herbicidal composition having a broad herbicidal spectrum has been desired. The present invention provides a synergistic herbicidal composition comprising (A) flazasulfuron or its salt and (B) at least one urea compound selected from the group consisting of tebuthiuron, diuron and metobromuron or its salt. According to the synergistic herbicidal composition of the present invention, a high active and long-residual herbicidal composition having a broad-spectrum can be provided.

Подробнее
11-04-2013 дата публикации

NOVEL SPECIFIC CASPASE-10 INHIBITORS

Номер: US20130090385A1

The invention relates to compounds of the general formula (I) wherein R1, R2, R3, R4, R5, R6, i and j have the meanings given in claim 1, and to the use thereof as caspase-10 inhibitors, especially for the treatment of diabetic retinopathy. 128.-. (canceled)301. A method according to Claim , in which R1 represents a phenyl group optionally substituted by one or more groups , which may be identical or different , chosen from a halogen atom and an -alkyl , —O-alkyl , —CO-alkyl , —NO , —O-perhaloalkyl , —S(O)-alkyl or -perhaloalkyl group , or two substituents together form a phenyl or pyridyl group fused to the phenyl nucleus to which they are attached; or R1 represents a cycloalkyl , heteroaryl or alkyl group.311. A method according to Claim , in which R1 represents a phenyl group substituted by at least one halogen atom.321. A method according to Claim , in which R2 and R3 together form a cycloalkyl group , optionally substituted by one or more alkyl groups; or R2 and R3 together form a heterocyclyl group.331. A method according to Claim , in which R5 represents a hydrogen atom or an alkyl group , optionally substituted by one or more cycloalkyl groups.341. A method according to Claim , in which R and R′ , which may be identical or different , independently represent a hydrogen atom or an alkyl group.351. A method according to Claim , in which i=2.361. A method according to Claim , in which j=0.371. A method according to Claim , in which the group —(CH)R4 is in the para position.391. A method according to Claim , wherein the compound is administered to a newly diagnosed diabetic patient and/or a patient suffering from early retinopathy and which comprises specifically inhibiting caspase-10 in the patient.4140. A compound of the formula (I) according to Claim , for which R1 represents a phenyl group optionally substituted by one or more groups , which may be identical or different , chosen from a halogen atom and an -alkyl , —O-alkyl , —CO-alkyl , —NO , —S(O)-alkyl , ...

Подробнее
11-04-2013 дата публикации

METHOD FOR PREPARING CHLOROHYDRINS AND METHOD FOR PREPARING EPICHLOROHYDRIN USING CHLOROHYDRINS PREPARED THEREBY

Номер: US20130090485A1
Принадлежит:

A method of preparing chlorohydrins and a method of preparing epichlorohydrin by using chlorohydrins prepared using the method are provided. The method of preparing chlorohydrins by reacting polyhydroxy aliphatic hydrocarbon with a chlorination agent in the presence of a catalyst includes at least one combination of a series of unit operations including a first reaction step, a water removal step, and a second reaction step, in that respective order, and after mixing at least a portion of a reaction mixture discharged from at least one reaction steps from among the plurality of reaction steps with an additional chlorination agent, recirculating the resulting mixture to the reaction step from which the reaction mixture was discharged. The method of preparing epichlorohydrin includes a step of reacting chlorohydrins prepared using the method of preparing chlorohydrins, with an alkaline agent. 1. A method of preparing chlorohydrins by reacting polyhydroxy aliphatic hydrocarbon with a chlorination agent in the presence of a catalyst , the method comprising at least one combination of a series of unit operations comprising a plurality of reaction steps and a water removal step in the following stated order:a first reaction step of reacting the polyhydroxy aliphatic hydrocarbon with the chlorination agent;a water removal step of removing water as a by-product from a reaction mixture discharged from the first reaction step; anda second reaction step of reacting at least one constituent of the dehydrated reaction mixture with at least one of the chlorination agent and an additional chlorination agent,wherein at least a portion of a reaction mixture discharged from at least one reaction steps from among the plurality of reaction steps is mixed with an additional chlorination agent, and the resulting mixture is then recirculated to the reaction step from which the reaction mixture was discharged.2. A method of preparing chlorohydrins , the method comprising:introducing ...

Подробнее
18-04-2013 дата публикации

USE OF STREPTOCOCCUS SALIVARIUS IN THE TREATMENT OF CHRONIC INFECTIONS OF THE RESPIRATORY TRACT

Номер: US20130095044A1
Принадлежит: D.M.G. ITALIA SRL

A new microbial strain of the species for use in the treatment of inflammatory processes with or without infectious etiology. A further object of the present invention compositions including the strain and uses thereof. 1S. salivarius. A pure bacterial strain belonging to the species deposited at the Deutsche Sammlung von Mikroorganismen and Zellkulturen GmbH , Braunschweig , Germany , under accession number DSM 23307.2. The bacterial strain according to useful for the treatment of upper respiratory tract infections and/or inflammation.3. The bacterial strain according to useful for the treatment of infections which are cause of diseases including acute otitis media claim 1 , recurrent otitis media claim 1 , sinusitis and or conditions characterized by inflammation such as nasal polyposis.4. The bacterial strain according to wherein the bacteria are in suspension claim 1 , freeze-dryed or inactivated claim 1 , provided they are not killed.5. Compositions comprising the bacterial strain according to useful for the treatment of upper respiratory tract infections and/or inflammation.6. Compositions comprising the bacterial strain according to useful for the treatment of infections which are cause of diseases including acute otitis media claim 1 , recurrent otitis media claim 1 , sinusitis and or conditions characterized by inflammation such as nasal polyposis.7. Compositions according to implemented by freeze-drying of bacterial culture claim 5 , by mixing freeze-dryed bacteria both in suspension with water or with further suitable excipients and optionally with addition of further active principles.8. Composition according to wherein the amount of bacteria is preferably in the range between 10and 10CFU for each gram of composition.9. Compositions according to comprising one or more pharmaceutically acceptable excipients claim 5 , aromatizing agents or carriers.10. Compositions according to wherein the used excipients are: rubber claim 9 , xanthan claim 9 , ...

Подробнее
18-04-2013 дата публикации

METHOD FOR PREPARING CHLOROHYDRINS AND METHOD FOR PREPARING EPICHLOROHYDRIN USING CHLOROHYDRINS PREPARED THEREBY

Номер: US20130096327A1
Принадлежит:

A method of preparing chlorohydrins and a method of preparing epichlorohydrin by using chlorohydrins prepared using the method are provided. The method of preparing chlorohydrins by reacting polyhydroxy aliphatic hydrocarbon with a chlorination agent in the presence of a catalyst includes at least one combination of a series of unit operations including a first reaction step, a water removal step, and a second reaction step, in that respective order, wherein the method further includes purifying chlorohydrins from a reaction mixture discharged from a final reaction step of the plurality of reaction steps. The method of preparing epichlorohydrin includes reacting chlorohydrins prepared using the method of preparing chlorohydrins, with an alkaline agent. 1. A method of preparing chlorohydrins by reacting polyhydroxy aliphatic hydrocarbon with a chlorination agent in the presence of a catalyst , the method comprising at least one combination of a series of unit operations comprising a plurality of reaction steps and a water removal step in the following stated order:a first reaction step of reacting the polyhydroxy aliphatic hydrocarbon with the chlorination agent;a water removal step of removing water as a by-product from a reaction mixture discharged from the first reaction step; anda second reaction step of reacting at least one constituent of the dehydrated reaction mixture with at least one of the chlorination agent and an additional chlorination agent,wherein the method further comprises purifying a reaction mixture discharged from a final reaction step of the plurality of reaction steps to obtain a concentrate of chlorohydrins.2. The method of claim 1 , further comprising mixing at least a portion of a reaction mixture discharged from at least one reaction steps from among the plurality of reaction steps claim 1 , with an additional chlorination agent and then recirculating the resultant mixture to the reaction step from which the reaction mixture was discharged ...

Подробнее
18-04-2013 дата публикации

METHOD FOR PRODUCING 1-AMINO-1-ALKOXYCARBONYL-2-VINYLCYCLOPROPANE

Номер: US20130096339A1
Принадлежит: API Corporation

It is an object of the present invention to provide a novel method for producing (1R,2S)/(1S,2R)-1-amino-1-alkoxycarbonyl-2-vinylcyclopropane which is useful as a synthetic intermediate of therapeutic agents for hepatitis C and a synthetic intermediate thereof. According to the present invention, when a trans-2-butene derivative having a leaving group at each of the 1- and 4-positions is reacted with a malonic ester in the presence of a base, a specific amount of an alkali metal alkoxide or an alkali metal hydride is used as the base, and further a specific amount of a malonic ester is used to produce a cyclopropane diester, and further, chiral or achiral 1-amino-1-alkoxy-carbonyl-2-vinylcyclopropane and a salt thereof are synthesized using the cyclopropane diester. 3. The method according to claim 1 , which comprises a step of purifying the compound represented by the formula (4) after performing the step (i).5. The method according to claim 4 , wherein the step (vi) is a step (vi-1) of allowing the compound represented by the formula (4) claim 4 , which has been obtained by the step (v) claim 4 , to react with an enzyme claim 4 , cells containing the enzyme claim 4 , a preparation of the cells claim 4 , or a culture solution obtained by culturing the cells claim 4 , so as to produce an optically active compound represented by the formula (5).8. The method according to claim 4 , wherein the absolute stereochemistry of the compound represented by the formula (5) is (1S claim 4 ,2S).10. The method according to claim 9 , wherein claim 9 , in the step (vii-1) claim 9 , the reaction intermediate is allowed to react with a metal azide compound or a trialkylsilyl azide in the presence of an acid.11. The method according to claim 9 , wherein the absolute stereochemistry of the compound represented by the formula (5) is (1S claim 9 ,2S) claim 9 , and the absolute stereochemistry of each of the compounds represented by the formula (6) claim 9 , the formula (7) and the ...

Подробнее
25-04-2013 дата публикации

METHOD FOR PREPARING CHLOROHYDRINS AND METHOD FOR PREPARING EPICHLOROHYDRIN USING CHLOROHYDRINS PREPARED THEREBY

Номер: US20130102798A1
Принадлежит: Samsung Fine Chemicals Co. Ltd

A method of preparing chlorohydrins and a method of preparing epichlorohydrin using chlorohydrins prepared by using the same method are provided. The method is to prepare chlorohydrins by reacting polyhydroxy aliphatic hydrocarbon with a chlorination agent in the presence of a catalyst, and the method includes at least one combination of a series of unit operations including the following steps in the following stated order: a first reaction step; a water removal step; and a second reaction step, wherein the water removing step is performed by distillation operation based on a boiling point difference between constituents of a reaction mixture. The method of preparing epichlorohydrin includes reacting chlorohydrins prepared by using the method of preparing chlorohydrins with an alkaline agent. 1. A method of preparing chlorohydrins by reacting polyhydroxy aliphatic hydrocarbon with a chlorination agent in the presence of a catalyst , the method comprising at least one combination of a series of unit operations comprising the following steps in the following stated order:a first reaction step for reacting polyhydroxy aliphatic hydrocarbon with a chlorination agent;a water removal step for removing water as a by-product from a reaction mixture discharged from the first reaction step; anda second reaction step for reacting at least one constituent of the reaction mixture from which water is removed, with at least one of the chlorination agent and an additional chlorination agent,wherein the reaction mixture introduced into the water removal step comprises polyhydroxy aliphatic hydrocarbon, chlorohydrins, and an intermediate product as a reaction product of the catalyst and the polyhydroxy aliphatic hydrocarbon at a ratio of 0 to 90 parts by weight of the polyhydroxy aliphatic hydrocarbon: 5 to 95 parts by weight of the chlorohydrins: 5 to 12 parts by weight of the intermediate product, andthe water removal step is performed by distillation based on a boiling point ...

Подробнее
25-04-2013 дата публикации

METHOD FOR PREPARING CHLOROHYDRINS COMPOSITION AND METHOD FOR PREPARING EPICHLOROHYDRIN USING CHLOROHYDRINS COMPOSITION PREPARED THEREBY

Номер: US20130102799A1
Принадлежит:

A method of preparing a chlorohydrin composition and a method of preparing epichlorohydrin by using a chlorohydrin composition prepared by using the method are provided. The method of preparing a chlorohydrin composition in which a polyhydroxy aliphatic hydrocarbon is reacted with a chlorination agent in the presence of a catalyst includes performing at least one combination of a series of unit operations comprising a first reaction step, a water removal step, and a second reaction step in this stated order, wherein the method further includes mixing a chlorohydrin concentrate obtained by purifying the reaction mixture discharged from the final reaction step from among the plurality of reaction steps and a water-rich layer discharged from the water-removal step. The method of preparing epichlorohydrin includes contacting the chlorohydrin composition prepared by using the method of preparing a chlorohydrin composition with an alkaline agent 1. A method of preparing a chlorohydrin composition in which a polyhydroxy aliphatic hydrocarbon is reacted with a chlorination agent in the presence of a catalyst , the method comprises at least one combination of a series of unit operations comprisinga first reaction step for reacting the polyhydroxy aliphatic hydrocarbon with the chlorination agent,a water removal step for separating a reaction mixture comprising water as a by-product discharged from the first reaction step into a water-rich layer and a water-deficient layer, anda second reaction step for reacting at least one constituent of the reaction mixture from which water is removed, with at least one of the chlorination agent and an additional chlorination agent,wherein these steps are performed in this stated order, and the method further comprisespurifying the reaction mixture discharged from the final reaction step from among the plurarity of reaction steps to obtain a chlorohydrin concentrate, andmixing the water-rich layer, and the chlorohydrin concentrate.2. A ...

Подробнее
25-04-2013 дата публикации

METHOD FOR PREPARING CHLOROHYDRINS COMPOSITION AND METHOD FOR PREPARING EPICHLOROHYDRIN USING CHLOROHYDRINS COMPOSITION PREPARED THEREBY

Номер: US20130102800A1
Принадлежит:

Disclosed are a method for preparing chlorohydrins composition and a method for preparing epichlorohydrin using chlorohydrins prepared thereby. The disclosed method for preparing chlorohydrins composition reacts polyhydroxy aliphatic hydrocarbon with a chlorination agent in the presence of a catalyst, comprises at least one combination of a series of unit operations including a first reaction step, a water removal step, and a second reaction step in the respective order, and additionally comprises a step for reacting the chlorohydrins composition derived from a plurality of reaction mixtures discharged from the plurality of reaction steps with an alkaline chemical, and removing the catalyst included in the chlorohydrins composition in the form of an alkali metal salt. The disclosed method for preparing epichlorohydrin includes a step for contacting the chlorohydrins composition, which was prepared using the method for preparing chlorohydrins composition, with an alkaline chemical. 1. A method for preparing chlorohydrins composition by reacting polyhydroxy aliphatic hydrocarbon with a chlorination agent in the presence of a catalyst , the method comprising at least one combination of a series of unit operations comprising the following steps in the following stated order:a first reaction step for reacting polyhydroxy aliphatic hydrocarbon with a chlorination agent;a water removal step for removing water as a by-product from a reaction mixture discharged from the first reaction step; anda second reaction step for reacting at least one constituent of the reaction mixture from which water is removed, with at least one of the chlorination agent and an additional chlorination agent,wherein the method additionally comprises a step for reacting the chlorohydrins composition derived from a plurality of reaction mixtures discharged from the plurality of reaction steps with an alkaline agent, and removing the catalyst comprised in the chlorohydrins composition in the form of ...

Подробнее
25-04-2013 дата публикации

METHOD FOR PREPARING CHLOROHYDRINS COMPOSITION AND METHOD FOR PREPARING EPICHLOROHYDRIN USING CHLOROHYDRINS COMPOSITION PREPARED THEREBY

Номер: US20130102801A1
Принадлежит:

Provided are a method of preparing a chlorohydrin composition and a method of preparing epichlorohydrin by using a chlorohydrin composition prepared by using the method. The method of preparing chlorohydrins in which polyhydroxy aliphatic hydrocarbon is reacted with a chlorination agent in the presence of a catalyst includes performing at least one combination of a series of unit operations comprising a first reaction step, a water removal step, and a second reaction step in this stated order, wherein the method further includes mixing a chlorohydrin concentrate obtained by purifying the reaction mixture discharged from the final reaction step from among the reaction steps and a water-rich layer discharged from the water-removal step and diluting the mixture with water. The method of preparing epichlorohydrin includes contacting the chlorohydrin composition prepared by using the method of preparing a chlorohydrin composition with an alkaline agent. 1. A method of preparing a chlorohydrin composition in which a polyhydroxy aliphatic hydrocarbon is reacted with a chlorination agent in the presence of a catalyst , the method comprises at least one combination of a series of unit operations comprisinga first reaction step for reacting the polyhydroxy aliphatic hydrocarbon with the chlorination agent,a water removal step for separating a reaction mixture comprising water as a by-product discharged from the first reaction step into a water-rich layer and a water-deficient layer, anda second reaction step for reacting at least one constituent of the reaction mixture from which water is removed with, at least one of the chlorination agent and an additional chlorination agent,wherein these steps are performed in this stated order, and the method further comprisespurifying the reaction mixture discharged from the final reaction step from among the plurality of reaction steps to obtain a chlorohydrin concentrate,mixing the water-rich layer and the chlorohydrin concentrate to ...

Подробнее
02-05-2013 дата публикации

AMIDE DERIVATIVES OF N-UREA SUBSTITUTED AMINO ACIDS AS FORMYL PEPTIDE RECEPTOR LIKE-1 (FPRL-1) RECEPTOR MODULATORS

Номер: US20130109866A1
Принадлежит: ALLERGAN, INC.

The present invention relates to novel amide derivatives of N-urea substituted amino acids, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of the N-formyl peptide receptor like-1 (FPRL-1) receptor. 2. A compound according to claim 1 , wherein:a is 1 and b is 0.3. A compound according to claim 1 , wherein:a is 1 and b is 0; and{'sup': 5', '14, 'sub': 'n', 'Ris —S(O)R.'}4. A compound according to claim 1 , wherein:a is 1 and b is 0; and{'sup': '5', 'sub': '3', 'Ris —CF.'}5) A compound according to claim 1 , wherein:a is 1 and b is 0; and{'sup': '5', 'Ris halogen.'}6. A compound according to claim 1 , wherein:a is 1 and b is 0;{'sup': 1', '11', '12', '13, 'sub': '1-8', 'Ris optionally substituted Calkyl, —NRRor —OR;'}{'sup': '2', 'sub': '1-8', 'Ris optionally substituted Calkyl;'}{'sup': 3', '15', '13', '11', '12, 'sub': '1-8', 'Ris hydrogen, optionally substituted Calkyl, halogen, —COOR, —OR, —NRR;'}{'sup': 4', '15', '13', '11', '12, 'sub': '1-8', 'Ris hydrogen, optionally substituted Calkyl, halogen, —COOR, —OR, —NRR;'}{'sup': 5', '14, 'sub': 3', 'n, 'Ris halogen, —CFor —S(O)R;'}n is 0, 1 or 2;{'sup': 6', '15', '13', '11', '−12, 'sub': '1-8', 'Ris hydrogen, optionally substituted Calkyl, halogen, —COOR, —OR, —NRR;'}{'sup': 7', '15', '13', '11', '12, 'sub': '1-8', 'Ris hydrogen, optionally substituted Calkyl, halogen, —COOR, —OR, —NRR;'}{'sup': '8', 'sub': '1-8', 'Ris hydrogen or optionally substituted Calkyl;'}{'sup': '9', 'sub': 1-8', '6-10, 'Ris hydrogen, optionally substituted Calkyl or optionally substituted Caryl;'}{'sup': '10', 'sub': '1-8', 'Ris hydrogen or optionally substituted C;'}{'sup': '11', 'sub': '1-8', 'Ris hydrogen or optionally substituted Calkyl;'}{'sup': '12', 'sub': '1-8', 'Ris hydrogen or optionally substituted Calkyl;'}{'sup': '13', 'sub': '1-8', 'Ris hydrogen or optionally substituted Calkyl;'}{'sup': '14', 'sub': '1-8', 'Ris hydrogen or optionally substituted Calkyl; ...

Подробнее
09-05-2013 дата публикации

PHARMACEUTICAL AND/OR DIETARY COMPOSITIONS BASED ON SORT CHAIN FATTY ACIDS

Номер: US20130115280A1
Автор: Moro Luigi
Принадлежит: COSMO TECHNOLOGIES LTD

Pharmaceutical and/or dietary compositions based on short chain fatty acids or salts, esters and/or amides thereof in combination with one or more dietary soluble or water-dispersible fibre and at least one flavouring agent are disclosed. 116-. (canceled)18. Composition according to claim 17 , wherein said butyric acid salts are selected among calcium butyrate claim 17 , sodium butyrate or magnesium butyrate.19. Composition according to claim 17 , wherein a quantity of from 5 to 60% by weight of the butyric acid or salts thereof is included claim 17 , preferably from 10 to 50% by weight claim 17 , with respect to the total weight of the composition.20. Composition according to claim 17 , wherein a quantity of from 5 to 50% by weight of the soluble or water-dispersible dietary fibre is included claim 17 , preferably from 10 to 30% by weight claim 17 , with respect to the total weight of the composition.21. Composition according to claim 17 , wherein a quantity of from 0.001% to 5% by weight claim 17 , of the flavouring agent is included claim 17 , preferably from 0.01 to 3% by weight claim 17 , with respect to the total weight of the composition.22. Composition according to in tablet claim 17 , capsule claim 17 , granule or micro-granule form.23. Composition according to wherein said coating is selected among a controlled-release coating claim 17 , a delayed release coating claim 17 , a modified release coating claim 17 , a taste-masking coating and/or a gastro-resistant coating.24. Composition according to claim 17 , wherein it is a controlled-release claim 17 , delayed-release claim 17 , modified-release claim 17 , taste-masking and/or gastro-resistant composition.25. A method of treating intestinal disorders claim 17 , inflammatory bowel diseases or disorders claim 17 , irritable bowel syndrome claim 17 , actinic colitis claim 17 , post-antibiotic dismicrobism and dismetabolism recovery claim 17 , acute and chronic diarrhoeal disorders and pathological conditions ...

Подробнее
09-05-2013 дата публикации

COMPOSITIONS FOR THE SYMPTOMATIC RELIEF OF STOMACH PAIN OR GASTROOESOPHAGEAL REFLUX

Номер: US20130115290A1
Принадлежит:

Compositions useful for relieving the symptoms commonly known as stomach acidity, heartburn or, more technically, esophageal reflux (GERD), that comprise a fatty acid and a plant extract. These compositions have been tried in patients with clinical records of previous diagnosis of GERD, chronic heartburn, or esophagitis, with a high degree of success. 2. The composition of claim 1 , wherein the plant extract from the alliaceae family is a garlic extract.3. The composition of claim 2 , wherein the garlic extract is powdered claim 2 , non-deodorized claim 2 , dry extract.4. The composition of claim 1 , wherein the alkali or alkaline-earth metal salt of at the least one C1-C10 fatty acid is a sodium claim 1 , calcium or potassium salt thereof.5. The composition of claim 4 , wherein the sodium claim 4 , calcium or potassium salt of the C1-C10 fatty acid is sodium butynate.6. The composition of claim 4 , wherein the sodium claim 4 , calcium or potassium salt of the C1-C10 fatty acid is buffered with a buffer selected front phosphate salts and carbonate salts.7. The composition of claim 1 , wherein the glycerol ester of at least one C1-C10 fatty acid is a triglyceride thereof.8. The composition of claim 1 , further comprising a curcuma plant extract.9. The composition of claim 1 , further comprising at least one excipient selected from the group consisting of vehiculizing agents claim 1 , thinners claim 1 , disintegrants claim 1 , lubricants claim 1 , binders claim 1 , gellants claim 1 , flavors claim 1 , sweeteners claim 1 , coloring agents claim 1 , preservatives claim 1 , fillers claim 1 , antioxidants claim 1 , encapsulating coadjuvants and coating agents.10. The composition of claim 1 , which is presented in the form of capsule claim 1 , pill claim 1 , sachet claim 1 , tablet or coated tablet.11. The composition of claim 1 , for the re-establishment of digestive homeostasis affected by peptic-acid disorders and/or states of disorder caused by damage to the gastric ...

Подробнее
16-05-2013 дата публикации

Use of Glyceryl Trinitrate for Treating Hematomas

Номер: US20130121930A1
Автор: Boskamp Marianne
Принадлежит: G. POHL-BOSKAMP GMBH & CO. KG

Use of glyceryl trinitrate (GTN) for treating hematomas. 1. Use of glyceryl trinitrate for treating hematomas.2. Use according to claim 1 ,wherein a composition comprising 0.2 to 2.0 percent by weight glyceryl trinitrate is administered topically.3. Use according to claim 2 ,wherein the composition comprises at least one excipient.4. Use according to claim 3 ,wherein the at least one excipient is selected from the group comprising medium-chain triglycerides, organic solvents, emulsifiers, water, propellants, preservatives, and penetration-assisting substances.54. Use according to one of through claims 2 ,wherein the composition is present in the form of a propellant spray or a pump spray.65. Use according to one of through claims 2 ,wherein the composition is present in the form of a propellant spray containing 40 to 70 percent by weight of a propellant and 30 to 60 percent by weight of a suitable solvent selected from the group comprising medium-chain triglycerides, water, ethanol, n-pentane, and propylene glycol, and mixtures thereof, in each case relative to the overall composition.7. Use according to claim 6 , wherein the propellant spray additionally contains a fragrance.85. Use according to one of through claims 2 ,wherein the composition is present in the form of a pump spray containing 30 to 50 percent by weight water and 20 to 70 percent by weight of an alcoholic solvent, in each case relative to the overall composition.9. Use according to claim 8 ,wherein the composition additionally contains 20 to 30 percent by weight glycerol, 5 to 10 percent by weight propylene glycol, and 0.15 to 4 percent by weight fragrance, in each case relative to the overall composition.105. Use according to through claims 2 ,wherein the composition is present as a pump spray containing 30 to 80 percent by weight of isopropanol, 5 to 25 percent by weight medium-chain triglycerides and 5 to 15 percent by weight triglyceroldiisotearate, in each case relative to the overall ...

Подробнее
16-05-2013 дата публикации

METHODS FOR ALLEVIATING CHRONIC PAIN AND IMPROVING PERFORMANCE OF CATTLE UNDERGOING DEHORNING OR CASTRATION

Номер: US20130123245A1

Methods of improving performance, increasing weight gain, and decreasing incidence of disease in ruminant and pre-ruminant animals, such as cattle, after undergoing painful processing procedures, such as castration and dehorning, are provided. Veterinary formulations for use in methods of the invention are also provided. The formulations comprise a compound selected from the group consisting of meloxicam, gabapentin, the pharmaceutically acceptable salts thereof, and combinations thereof. Methods of treating pathological pain in cattle are also provided. 14-. (canceled)5. A method of improving the performance of a ruminant or pre-ruminant animal following processing , comprising:orally administering to said animal an effective amount of meloxicam or a pharmaceutically acceptable salt thereof; andsubjecting said animal to processing, wherein said animal has improved performance after said processing.6. The method of claim 5 , wherein said animal is a bovine.7. The method of claim 5 , wherein said processing is selected from the group consisting of dehorning claim 5 , castration claim 5 , branding claim 5 , and combinations thereof.8. The method of claim 5 , wherein said meloxicam or pharmaceutically acceptable salt thereof is administered to said animal in an amount sufficient to provide a level of meloxicam of from about 0.1 mg/kg body weight to about 5 mg/kg body weight of said animal.9. The method of claim 5 , wherein said meloxicam or pharmaceutically acceptable salt thereof is in the form of a tablet claim 5 , capsule claim 5 , liquid claim 5 , granule claim 5 , top-dress claim 5 , suspension claim 5 , bolus claim 5 , drench claim 5 , solution claim 5 , topical pour-on claim 5 , sustained-release implant claim 5 , or rectal suppository.10. The method of claim 5 , wherein said meloxicam is administered to said animal up to about 72 hours before said processing.11. The method of claim 5 , wherein said improved performance is selected from the group consisting of ...

Подробнее
16-05-2013 дата публикации

Metabolic Benefits to Butyrate as a Chronic Diet Supplement

Номер: US20130123358A1
Автор: Gao Zhanguo, Ye Jianping
Принадлежит:

Sodium butyrate was chronically administrated through diet supplementation at 5% w/w in a high fat diet. Supplementation of butyrate prevented development of insulin resistance and obesity in C57BL/6J mice on a high fat diet, and in mice fed on a regular diet of tributyrin. Fasting blood glucose, insulin, and insulin tolerance were all reserved in the butyrate-treated mice. The body fat content was maintained at 10% without a reduction in food intake. Adaptive thermogenesis and fatty acid oxidation were enhanced. An increase in mitochondria function and biogenesis was observed in the skeletal muscle and brown fat, and Type 1 muscle fiber was enriched in the skeletal muscle. In genetically obese mice, supplementation of butyrate led to an increase in insulin sensitivity and reduction in adiposity. Dietary supplementation of butyrate can prevent and treat diet-induced insulin resistance. 1. A method to increase the sensitivity of a non-ruminant mammal to insulin , said method comprising chronically administering to the mammal with low sensitivity to insulin a therapeutically effective dose of a compound selected from the group consisting of butyric acid and its isoforms.2. The method as in claim 1 , wherein the non-ruminant mammal is on a high fat diet.3. A method as claim 1 , in which the butyric acid isoforms are one or more isoforms selected from the group consisting of butyl butyrate claim 1 , amyl butyrate claim 1 , isobutyl butyrate claim 1 , benzyl butyrate claim 1 , a-methylbenzyl butyrate claim 1 , hexyl butyrate claim 1 , heptyl butyrate claim 1 , pennetyl butyrate claim 1 , methyl butyrate claim 1 , and 2-hydroxy-3-methylbutanoic acid.4. The method as in claim 1 , wherein the compound is administered in the form of a triglyceride.5. The method as in claim 1 , wherein the dose of the compound administered orally is from about 2% to about 10% wt/wt total food intake of the mammal.6. The method as in claim 1 , wherein the dose of the compound administered ...

Подробнее
16-05-2013 дата публикации

FIVE AND FIFTEEN CARBON FATTY ACIDS FOR TREATING METABOLIC DISORDERS AND AS NUTRITIONAL SUPPLEMENTS

Номер: US20130123359A1
Автор: Roe Charles R.
Принадлежит: BAYLOR RESEARCH INSTITUTE

According to the present invention, acquired metabolic derangements or fatty acid disorders in humans that are manifested by a deficiency in at least one enzyme involved in fatty acid metabolism are treated with a five carbon or a fifteen carbon fatty acid source. Rapid nutritional supplementation can also be provided to a mammalian cell by providing either a five carbon or fifteen carbon fatty acid source. Dietary formulations suitable for human consumption comprising either a five carbon fatty acid, a fifteen carbon fatty acid or triglycerides thereof is also disclosed. 1. A method for treating acquired metabolic derangements or fatty acid disorders in humans that are manifested by a deficiency in at least one enzyme involved in fatty acid metabolism , comprising treating said human with a five carbon fatty acid source.2. A method for treating fatty acid disorders in humans that are manifested by a deficiency in at least one enzyme involved in fatty acid metabolism , comprising treating said human with a fifteen carbon fatty acid source.3. The method of claim 1 , wherein said fatty acid disorder is MCAD.4. The method of claim 1 , wherein said fatty acid disorder is SCAD.5. The method of claim 1 , wherein said fatty acid disorders are selected from VLCAD claim 1 , MTP claim 1 , and LCHAD.6. The method of claim 2 , wherein said fatty acid disorder is SCAD.7. The method of claim 2 , wherein said fifteen carbon fatty acid is administered orally.8. A method for providing rapid nutritional supplementation to a mammalian cell claim 2 , comprising providing a five carbon fatty acid source to said cell.9. A method for providing rapid nutritional supplementation to a mammalian cell claim 2 , comprising providing a fifteen carbon fatty acid source to said cell.10. A method for providing nutritional supplementation to a human or animal claim 2 , comprising providing a fatty acid source comprising five carbons claim 2 , administered enterally or parenterally.11. A method for ...

Подробнее
16-05-2013 дата публикации

Method for Functionalizing Natural Fatty Substances

Номер: US20130123456A1
Принадлежит:

The invention relates to a method for functionalizing natural fatty substances: According to said method, plant oils including at least two unsaturations and the derivatives thereof, fatty acids including at least one unsaturated compound and the derivatives thereof, and mixtures of same, are reacted with a thiol derivative of formula (I), at a temperature of between 0° C. and the temperature of total degradation of the natural fatty substance and in the presence of a thermal initiator compound or a redox initiator, or by UV radiation, or by UV radiation and in the presence of a photoinitiator. The invention also relates to the resulting functionalized fatty substances and to the use thereof for the preparation of polymers. The invention further relates to a method for preparing polymers from at least one functionalized fatty substance obtained by said functionalization method. 4. The method according to in which the vegetable oil and the derivatives thereof comprise between 2 and 20 unsaturations.5. The method according to in which the vegetable oil is chosen from among natural crude or purified vegetable oils claim 3 , and vegetable oils derived from genetically modified plants or cultures.6. The method according to in which the vegetable oil is chosen from among canola oil claim 5 , safflower oil claim 5 , rapeseed oil claim 5 , cottonseed oil claim 5 , linseed oil claim 5 , corn oil claim 5 , hazelnut oil claim 5 , coconut oil claim 5 , olive oil claim 5 , palm oil claim 5 , grape-seed oil claim 5 , castor oil claim 5 , sesame oil claim 5 , soybean oil claim 5 , sunflower oil claim 5 , alone or in a mixture.7. The method according to in which the derivatives of vegetable oils are fatty esters obtained by esterification or transesterification of the vegetable oils in claim 5 , fatty amides obtained by amidification or transamidification of the vegetable oils in claim 5 , partly epoxidated oils.8. The method according to in which the fatty acids and their ...

Подробнее
23-05-2013 дата публикации

Use of Glyceryl Trinitrate for Treating Traumatic Edema

Номер: US20130129638A1
Автор: Boskamp Marianne
Принадлежит: G. POHL-BOSKAMP GMBH & CO. KG

Use of glyceryl trinitrate (GTN) for treating traumatic edemas. 1. Use of glyceryl trinitrate for treating traumatic edema.2. Use according to claim 1 ,wherein a composition comprising 0.2 to 2.0 percent by weight glyceryl trinitrate is administered topically.3. Use according to claim 2 ,wherein the compositions comprises at least one excipient.4. Use according to claim 3 ,wherein the at least one excipient is selected from the group comprising medium-chain triglycerides, organic solvents, emulsifiers, water, propellants, preservatives, and penetration-assisting substances.54. Use according to one of through claims 2 ,wherein the composition is present in the form of a propellant spray or a pump spray.65. Use according to one of through claims 2 ,wherein the composition is present in the form of a propellant spray containing 40 to 70 percent by weight of a propellant and 30 to 60 percent by weight of a suitable solvent selected from the group comprising medium-chain triglycerides, water, ethanol, n-pentane, and propylene glycol, and mixtures thereof, in each case relative to the overall composition.7. Use according to claim 6 , wherein the propellant spray additionally contains a fragrance.85. Use according to one of through claims 2 ,wherein the composition is present in the form of a pump spray containing 30 to 50 percent by weight water and 20 to 70 percent by weight of an alcoholic solvent, in each case relative to the overall composition.9. Use according to claim 8 ,wherein the composition additionally contains 20 to 30 percent by weight glycerol, 5 to 10 percent by weight propylene glycol, and 0.15 to 4 percent by weight fragrance, in each case relative to the overall composition.105. Use according to through claims 2 ,wherein the composition is present as a pump spray containing 30 to 80 percent by weight of isopropanol, 5 to 25 percent by weight medium-chain triglycerides and 5 to 15 percent by weight triglyceroldiisotearate, in each case relative to the ...

Подробнее
23-05-2013 дата публикации

DEFOLIANT COMPOSITION AND METHOD

Номер: US20130130901A1
Принадлежит: ARYSTA LIFESCIENCE NORTH AMERICA, LLC

An aqueous suspension or slurry (suspension concentrate) contains a synergistic amount of thidiazuron, diuron and surfactants. The aqueous suspension contains surfactants in amounts to obtain a stable suspension or slurry without the use of organic solvents. 1. A composition for controlling vegetation comprising an aqueous suspension or slurry of thidiazuron , diuron , and at least one surfactant in an amount sufficient to maintain thidiazuron and diuron in suspension in an aqueous matrix.2. The composition of claim 1 , wherein said thidiazuron and diuron are present in a ratio of about 5:1 by weight.3. The composition of claim 1 , wherein said diuron is present in a synergistic amount to enhance the efficacy of the thidiazuron.4. The composition of claim 1 , wherein the composition further includes at least one component selected from the group consisting of emulsifiers claim 1 , wetting agents claim 1 , thickening agents claim 1 , dispersing agents claim 1 , and mixtures thereof.5. (canceled)6. The composition of claim 1 , wherein the composition is a suspension concentrate.7. The composition of claim 6 , wherein the concentrate includes about 10 wt % to about 40 wt % thidiazuron and about 5 wt % to about 20 wt % diuron based on the total weight of the concentrate.8. The composition of claim 6 , wherein the concentrate includes about 35 wt % to about 40 wt % thidiazuron and about 15 wt % to about 20 wt % diuron based on the total weight of the concentrate.9. The composition of claim 6 , further comprising a dispersing agent.10. The composition of claim 9 , wherein the thidiazuron and diuron have a median particle diameter of not greater than about 5 μm.11. The composition of claim 9 , wherein the concentrate comprises about 10 wt % to about 40 wt % thidiazuron claim 9 , about 5 wt % to about 20 wt % diuron claim 9 , a surfactant claim 9 , a dispersing agent and the balance water claim 9 , where the percentages are based on the total weight of the concentrate.12. ...

Подробнее
23-05-2013 дата публикации

N-HYDROXYFORMAMIDE DERIVATIVE AND MEDICAMENT CONTAINING SAME

Номер: US20130131180A1
Принадлежит: KAKEN PHARMACEUTICAL CO., LTD.

A compound represented by the following general formula (I) which has ADAM17 inhibitory activity, or a salt thereof, or a solvate thereof: 2. The compound or a salt thereof or a solvate thereof according to claim 1 , wherein the compound represented by the general formula (I) is the following: N-[2-(4-but-2-ynyloxybenzenesulfonyl)-1-(4-diethylaminomethylphenyl)ethyl]-N-hydroxyformamide claim 1 , N-[2-(4-but-2-ynyloxybenzenesulfonyl)-1-(4-dimethylaminomethylphenyl)ethyl]-N-hydroxyformamide claim 1 , N-{4-[2-(4-but-2-ynyloxybenzenesulfonyl)-1-(formylhydroxyamino)ethyl]benzyl}-2-methoxyacetamide claim 1 , N-{4-[2-(4-but-2-ynyloxybenzenesulfonyl)-1-(formylhydroxyamino)ethyl]benzyl}methanesulfonamide claim 1 , N-{4-[2-(4-but-2-ynyloxybenzenesulfonyl)-1-(formylhydroxyamino)ethyl]benzyl}benzamide claim 1 , N-[2-(4-but-2-ynyloxybenzenesulfonyl)-1-(4-morpholin-4-ylmethylphenyl)ethyl]-N-hydroxyformamide claim 1 , N-hydroxy-N-[1-(4-morpholin-4-ylmethylphenyl)-2-(4-pent-2-ynyloxybenzenesulfonyl)ethyl]formamide claim 1 , N-[2-(4-but-2-ynyloxybenzenesulfonyl)-1-(4-dimethylaminophenyl)ethyl]-N-hydroxyformamide claim 1 , N-[2-(4-but-2-ynyloxybenzenesulfonyl)-1-(3-dimethylaminophenyl)ethyl]-N-hydroxyformamide claim 1 , N-[2-(4-but-2-ynyloxybenzenesulfonyl)-1-(2-dimethylaminophenyl)ethyl]-N-hydroxyformamide claim 1 , N-[2-(4-but-2-ynyloxybenzenesulfonyl)-1-(4-piperidin-1-ylmethylphenyl)ethyl]-N-hydroxyformamide claim 1 , N-[2-(4-but-2-ynyloxybenzenesulfonyl)-1-(3-piperidin-1-ylmethylphenyl)ethyl]-N-hydroxyformamide claim 1 , N-[2-(4-but-2-ynyloxybenzenesulfonyl)-1-(3-morpholin-4-ylmethylphenyl)ethyl]-N-hydroxyformamide claim 1 , N-[2-(4-but-2-ynyloxybenzenesulfonyl)-1-{4-[(ethylmethylamino)methyl]phenyl}ethyl]-N-hydroxyformamide claim 1 , N-(2-(4-but-2-ynyloxybenzenesulfonyl)-1-{3-[(ethylmethylamino)methyl]phenyl}ethyl)-N-hydroxyformamide claim 1 , N-{4-[2-(4-but-2-ynyloxybenzenesulfonyl)-1-(formylhydroxyamino)ethyl]benzyl}-N-methylmethanesulfonamide claim 1 , N-{4-[2-(4-but-2- ...

Подробнее
23-05-2013 дата публикации

POLYOL, POLYOL COMPOSITION, AND FLEXIBLE POLYURETHANE FOAM USING THE SAME

Номер: US20130131208A1
Принадлежит: Mitsui Chemicals, Inc.

Disclosed are a polyol with a molecular weight distribution Mw/Mn of 4 or more, obtained by reacting a compound comprising an alkylene oxide compound (II) having a hydroxyl group in a base polyol (I) with a molecular weight of 2000 or more; and a polyol composition for a flexible polyurethane foam, comprising a polyol compound and a crosslinker, wherein the crosslinker comprises a polyol (a) with a hydroxyl value of 50 to 1100 mgKOH/g and with a primary hydroxylate ratio of 25% or more and 60% or less, which is obtained by an addition of a compound comprising alkylene oxide compound (ii) having a hydroxyl group to active hydrogen compound (i). 1. A polyol with a molecular weight distribution Mw/Mn of 4 or more , obtained by reacting a compound comprising an alkylene oxide compound (II) having a hydroxyl group in a base polyol (I) with a molecular weight of 2000 or more.2. The polyol according to claim 1 , having at least one maximum value in the molecular weight distribution curve which exists in an area of higher molecular weight than that of the base polyol (I).3. The polyol according to claim 2 , wherein the maximum value existing in the area of higher molecular weight than that of the base polyol (I) is caused by a polyol which is obtained by an addition polymerization of the compound comprising the alkylene oxide compound (II) having a hydroxyl group to a hydroxyl group of the base polyol (I).4. The polyol according to claim 2 , wherein an area S1 of the base polyol (I) and an area S2 exist in the in the molecular weight distribution curve claim 2 , and the area S2 is an area of higher molecular weight than the area S1 claim 2 , and an area ratio of the area S1 and the area S2 claim 2 , i.e. S1/S2 is from 99/1 to 20/80.5. The polyol according to claim 1 , wherein the compound (II) comprises an epoxide having a hydroxyl group.6. The polyol according to claim 5 , wherein the epoxide having a hydroxyl group comprises glycidol.7. The polyol according to claim 6 , ...

Подробнее
23-05-2013 дата публикации

PREPARATION OF CHALCONE DERIVATIVES

Номер: US20130131372A1
Принадлежит: GENFIT

The invention relates to methods for producing chalcone (1,3-diphenylprop-2-en-1-one) derivatives that have multiple substitutions on a phenyl ring. Intermediate chalcone derivatives are modified by Phase Transfer Catalysis (PTC) for introducing a substituted alkyl group that is provided by a sulfonic acid derivative on a phenyl ring already containing substituent groups on one or two carbon atoms adjacent to the carbon atom where a substituent group is being introduced. The methods of the invention allow producing efficiently, by either S-alkylation or O-alkylation, chalcones derivatives that are characterized for their biological activities that are intermediate compounds for producing molecules having such activities, or that can be used for generating libraries of compounds to be screened by means of in vitro and/or in vivo assays and establishing structure-activity relationships. 115.-. (canceled)17. The method of claim 16 , wherein Rgroup is an unsubstituted alkyl or alkenyl group having from two to seven carbon atoms.18. The method of claim 16 , wherein L group is CO—CH═CH claim 16 , CO—CH—CH claim 16 , CH═CH—CO or CH—CH—CO.19. The method of claim 16 , wherein one of the substituent groups among X claim 16 , X claim 16 , X claim 16 , X claim 16 , and Xof General Formula (I) and (I) is a halogen claim 16 , a Ra or Ga—Ra group and the other four substituent groups among X claim 16 , X claim 16 , X claim 16 , X claim 16 , and Xgroups are hydrogen atoms.20. The method of claim 16 , wherein Xof General Formula (I) and (I) is a halogen claim 16 , a Ror G-Rgroup and the other four substituent groups among X claim 16 , X claim 16 , X claim 16 , and Xgroups are hydrogen atoms.21. The method of claim 16 , wherein the Xsubstituent group of General Formula (I) that claim 16 , after step (b) becomes a G-Rgroup claim 16 , is a G-H group.22. The method of claim 16 , wherein Gis an oxygen atom.23. The method of claim 16 , wherein the compounds of General Formula (I) and (I) ...

Подробнее
30-05-2013 дата публикации

Compound Used to Prevent Diseases Caused by Aquaporin Deficiency

Номер: US20130137766A1
Автор: Hung Chi-Feng
Принадлежит: FU-JEN CATHOLIC UNIVERSITY

A compound used to prevent diseases caused by aquaporin deficiency, which is 18β-Glycyrrhetinic acid derivative. Said compound can not only prevent diseases caused aquaporin deficiency, but be able to prevent aquaporin (AQP) production and enhance skin function. Since AQPs have many advantages in skin cells, e.g. promoting water and glycerine molecular transportation, increasing skin elasticity and cuticle moisture, increasing the cell proliferation and cell migration, aquaporin can promote skin bather function and wound cicatrization. Therefore, said compound can be applied potentially as a medicinal cosmetic in skin medicine cosmetology, or as a new medical composition to treat diseases caused by AQP abnormality, such as urine concentration defect, wound healing slow down, corneal re-epithelialization slow down and etc. 1. A method for preventing diseases caused by aquaporin deficiency with a novel compound , wherein the novel compound is a 18β-glycyrrhetinic acid derivative , the chemical structure of which is shown in , wherein R is selected from one of the following functional groups: H , CH , CH(CH) , and CHPh.2. The method as claimed in claim 1 , wherein the 18β-glycyrrhetinic acid derivative is a pharmaceutically-acceptable salt of 18β-glycyrrhetinic acid.3. The method as claimed in claim 1 , wherein the 18β-glycyrrhetinic acid derivative is a solvate of 18β-glycyrrhetinic acid.4. The method as claimed in claim 1 , wherein the 18β-glycyrrhetinic acid derivative is a pharmaceutically active derivative of 18β-glycyrrhetinic acid.5. The method as claimed in claim 1 , wherein the novel compound can increase AQP-3 expression in fibroblasts.6. The method as claimed in claim 1 , wherein the novel compound can increase AQP-3 expression in human keratinocytes.7. The method as claimed in claim 1 , wherein the novel compound is used for glycerol transport.8. The method as claimed in claim 1 , wherein the novel compound is used to increase the number of fibroblast.9. ...

Подробнее
30-05-2013 дата публикации

PROCESS FOR PREPARING SULFUR-CONTAINING 2-KETOCARBOXYLATE COMPOUND

Номер: US20130137896A1
Принадлежит: Sumitomo Chemical Company, Limited

The present invention provides a novel process for preparing a sulfur-containing 2-ketocarboxylate compound without using any enzyme. The process comprises a step of oxidizing a hydroxyacetate compound having an optionally-substituted sulfur-containing hydrocarbon group at 2-position in the presence of ruthenium metal or a ruthenium compound. Preferably, the step is carried out under pressurized condition, and more preferably, in the presence of at least one typical metal selected from the group consisting of an alkali metal compound and an alkaline earth metal compound. 1. A process for preparing a sulfur-containing 2-ketocarboxylate compound comprising a step of oxidizing a hydroxyacetate compound having an optionally-substituted sulfur-containing hydrocarbon group at 2-position in the presence of at least one catalyst selected from the group consisting of a ruthenium metal and a ruthenium compound.2. The process of wherein the step of oxidizing a hydroxyacetate compound having an optionally-substituted sulfur-containing hydrocarbon group at 2-position is carried out under pressurized condition.3. The process of or wherein the step of oxidizing a hydroxyacetate compound having an optionally-substituted sulfur-containing hydrocarbon group at 2-position is carried out in the presence of at least one typical metal compound selected from the group consisting of an alkali metal compound and an alkaline earth metal compound.4. The process of wherein the typical metal compound is an alkali metal hydroxide.5. The process of wherein the step of oxidizing a hydroxyacetate compound having an optionally-substituted sulfur-containing hydrocarbon group at 2-position is carried out in the presence of oxygen claim 1 ,7. The process of wherein Ris methyl group and n is 2. The present invention relates to a process for preparing a sulfur-containing 2-ketocarboxylate compound.It is known that sulfur-containing 2-ketocarboxylate compounds such as 4-methylthio-2-oxobutyric acid are, ...

Подробнее
30-05-2013 дата публикации

PROCESS FOR PREPARING SULFUR-CONTAINING 2-KETOCARBOXYLATE COMPOUND

Номер: US20130137897A1
Принадлежит: Sumitomo Chemical Company, Limited

The present invention provides a novel process for preparing a sulfur-containing 2-ketocarboxylate compound without using any enzyme. The process comprises a step of oxidizing a hydroxyacetate compound having an optionally-substituted sulfur-containing hydrocarbon group at 2-position in the presence of a vanadium compound. Preferably, the step is carried out further in the presence of oxygen, and more preferably, in the presence of an organic solvent. 1. A process for preparing a sulfur-containing 2-ketocarboxylate compound comprising a step of oxidizing a hydroxyacetate compound having an optionally-substituted sulfur-containing hydrocarbon group at 2-position in the presence of a vanadium compound.2. The process of wherein the step of oxidizing a hydroxyacetate compound having an optionally-substituted sulfur-containing hydrocarbon group at 2-position is carried out in the presence of oxygen.3. The process of wherein the step of oxidizing a hydroxyacetate compound having an optionally-substituted sulfur-containing hydrocarbon group at 2-position is carried out in the presence of an organic solvent.4. The process of wherein the organic solvent is at least one solvent selected from the group consisting of a ketone solvent claim 3 , a nitrile solvent and an aromatic solvent.5. The process of wherein the vanadium compound is at least one compound selected from the group consisting of a trivalent vanadium compound claim 1 , a tetravalent vanadium compound and a pentavalent vanadium compound.7. The process of wherein Ris methyl group and n is 2. The present invention relates to a process for preparing a sulfur-containing 2-ketocarboxylate compound.It is known that sulfur-containing 2-ketocarboxylate compounds such as 4-methylthio-2-oxobutyric acid are, for example, useful intermediates for preparing medicaments and agrochemicals.A conventional process for preparing a sulfur-containing 2-ketocarboxylate compound is disclosed in, for example, Non-patent Document 1. In ...

Подробнее
06-06-2013 дата публикации

METHOD OF PREVENTING AND TREATING INFLAMMATORY DISEASES AND DISORDERS WITH ABSCISIC ACID

Номер: US20130142825A1

The present invention relates to the use of a therapeutically effective amount of abscisic acid (ABA) or its analogs to treat or prevent inflammation induced by exposure to lipopolysaccharide (LPS) or respiratory inflammation. The invention also relates to methods and composition for enhancing vaccine efficacy using ABA. 12. A method of preventing or treating LPS-induced inflammation in a mammal , the method comprising administering to the mammal in need thereof a composition containing one or more compounds selected from: abscisic acid (ABA) in its free acid form , esters thereof , pharmaceutically suitable salts thereof , metabolites thereof , structurally related compounds thereof , and analogs thereof , in an amount that is sufficient to bind LANCL and alter the expression or activity of PPAR γ in a cell of the mammal.2. The method of claim 1 , wherein the composition further comprises a carrier that has substantially no effect on the expression or activity of PPAR γ in a cell of the mammal.3. The method of claim 2 , wherein the carrier is a pharmaceutical carrier claim 2 , a nutritional supplement claim 2 , a functional food claim 2 , or a dietary aid.4. The method of claim 1 , wherein the one or more compounds is greater than about 95% pure.5. The method of claim 1 , wherein the one or more compounds is abscisic acid in its free acid form.6. The method of claim 1 , wherein the abscisic acid in its free acid form is chemically synthesized.7. The method of claim 1 , which is a method of treating a subject having or having a predisposition to develop a disease or disorder that can be exacerbated or worsened when the amounts of LPS in blood are increased such as Parkinson's Disease claim 1 , immune mediated diseases claim 1 , metabolic syndrome claim 1 , kidney disease and Alzheimer's Disease.8. The method of claim 1 , which is a method of treating a subject having or having a predisposition to develop obesity-related co-morbidities by decreasing the effects of ...

Подробнее
06-06-2013 дата публикации

PROCESS FOR PRODUCING METHIONINE

Номер: US20130143279A1
Принадлежит: Sumitomo Chemical Company, Limited

The present invention relates to a process for producing methionine, comprising a first step of reacting 2-amino-3-buten-1-ol with methanethiol, and a second step of oxidizing 2-amino-4-methylthio-1-butanol obtained in the first step. The present invention also relates to a process for producing 2-amino-4-methylthio-1-butanol, comprising a step of reacting 2-amino-3-buten-1-ol with methanethiol. 1. A process for producing methionine , comprising a first step of reacting 2-amino-3-buten-1-ol with methanethiol , and a second step of oxidizing 2-amino-4-methylthio-1-butanol obtained in the first step.2. The process according to claim 1 , wherein the first step is a step of reacting 2-amino-3-buten-1-ol with methanethiol in the presence of a radical initiator.3. The process according to claim 2 , wherein the radical initiator is an azo compound.4. The process according to claim 1 , wherein the first step is a step of reacting 2-amino-3-buten-1-ol with methanethiol in the presence of a solvent.5. The process according to claim 4 , wherein the solvent is an ester solvent.6. The process according to claim 1 , wherein the second step is a step of oxidizing 2-amino-4-methylthio-1-butanol in the presence of at least one metal selected from the group consisting of copper and the elements belonging to Group 8 claim 1 , 9 or 10 of the periodic table.7. The process according to claim 1 , wherein the second step is a step of oxidizing 2-amino-4-methylthio-1-butanol in the presence of copper and water.8. The process according to claim 1 , wherein the second step is a step of oxidizing 2-amino-4-methylthio-1-butanol in the presence of oxygen and either ruthenium or platinum.9. The process according to claim 6 , wherein the second step is a step of oxidizing 2-amino-4-methylthio-1-butanol further in the presence of at least one typical metal compound selected from the group consisting of alkali metal compounds and alkaline earth metal compounds.10. The process according to the claim ...

Подробнее
06-06-2013 дата публикации

MICROBIOLOGICALLY SOUND AND STABLE SOLUTIONS OF GAMMA-HYDROXYBUTYRATE SALT FOR THE TREATMENT OF NARCOLEPSY

Номер: US20130143965A1
Принадлежит: Jazz Pharmaceuticals, Inc.

Disclosed are formulations of gamma-hydroxybutyrate in an aqueous medium that are resistant to microbial growth. Also disclosed are formulations of gamma-hydroxybutyrate that are also resistant to the conversion into GBL. Disclosed are methods to treat sleep disorders, including narcolepsy, with these stable formulations of GHB. The present invention also provides methods to treat alcohol and opiate withdrawal, reduced levels of growth hormone, increased intracranial pressure, and physical pain in a patient. 19-. (canceled)10. A pharmaceutical composition , comprising an aqueous solution of between about 350 and 750 mg/ml of a salt of gamma-hydroxybutyrate , wherein the composition has a pH of between about 7.0 to about 9.0 , wherein the composition is chemically stable and resistant to microbial growth , and wherein the composition is free of preservatives.11. A composition in accordance with claim 10 , wherein the salt is selected from the group consisting of sodium claim 10 , ammonium claim 10 , calcium and magnesium forms of gamma-hydroxybutyrate.12. A composition in accordance with claim 10 , wherein the salt is selected from the group consisting of sodium and calcium forms of gamma-hydroxybutyrate.13. A composition in accordance with claim 10 , wherein the aqueous composition contains a salt selected from the group consisting of lithium claim 10 , potassium claim 10 , sodium claim 10 , calcium claim 10 , ammonium claim 10 , and magnesium.14. A composition in accordance with claim 10 , wherein the aqueous composition contains a salt selected from the group consisting of potassium claim 10 , sodium claim 10 , calcium claim 10 , and magnesium.15. The pharmaceutical composition of claim 10 , wherein the composition has a pH of between about 7.3 to about 8.5.16. The pharmaceutical composition of claim 10 , wherein the composition additionally comprises a pH adjusting or buffering agent.17. The pharmaceutical composition of claim 16 , wherein the pH adjusting or ...

Подробнее
13-06-2013 дата публикации

MODULATORS OF RETINOID-RELATED ORPHAN RECEPTOR GAMMA

Номер: US20130150333A1
Принадлежит: ORPHAGEN PHARMACEUTICALS

Methods for modulating (inhibiting or stimulating) retinoid-related orphan receptor γ (RORγ) activity. This modulation has numerous effects, including inhibition of T-17 cell function and/or T-17 cell activity, and inhibition of re-stimulation of T-17 cells, which are beneficial to treatment of inflammation and autoimmune disorders. Stimulation of RORγ results in stimulation of T-17 cell function and/or activity which is beneficial for immune-enhancing compositions (e.g., vaccines). 1. A method of inhibiting T-17 cell differentiation , function or activity in an individual afflicted with multiple sclerosis , psoriasis , Crohn's disease , asthma , rheumatoid arthritis , uveitis or psoriatic arthritis , comprising administering to said individual an effective amount of a small organic molecule antagonist of RORγ , wherein said small organic molecule antagonist has a molecular weight of less than about 600 daltons , wherein the ability of said small organic molecule to act as a RORγ antagonist is demonstrable by its ability to inhibit transcription through the RORγ ligand binding domain and to regulate the affinity of the RORγ ligand binding domain with a coregulatory peptide at concentrations of 1 μM or less.2. The method of claim 1 , wherein said T-17 cell function or activity is release of a cytokine.3. The method of claim 2 , wherein said cytokine is interleukin-17 or interleukin-22.4. The method of claim 1 , wherein the RORγ antagonist is orally administered.5. The method of wherein the RORγ antagonist is locally administered.6. The method of wherein said effective amount of a RORγ antagonist is administered on a daily basis without resulting in weight loss or hypertriglyceridemia.7. The method of claim 1 , wherein the coregulatory peptide binding is measured by a method selected from the group consisting of fluorescence resonance energy transfer (FRET) claim 1 , fluorescence polarization claim 1 , time-resolved FRET (TR-FRET) and Alpha Screen.8. A method of ...

Подробнее
13-06-2013 дата публикации

MODIFIED RELEASE COMPOSITIONS OF MAGNESIUM VALPROATE

Номер: US20130150444A1
Принадлежит: CADILA HEALTHCARE LIMITED

The present invention relates to a modified release pharmaceutical composition comprising therapeutically effective amounts of magnesium valproate and/or its pharmaceutically acceptable solvates or mixtures thereof and at least one rate controlling polymer. Rate controlling polymer is either hydrophilic or hydrophobic in nature. Mixture of the rate controlling material or more is also used to provide formulations of the present invention. 1. A modified release pharmaceutical composition comprising magnesium valproate or its pharmaceutically acceptable solvates , one or more rate controlling polymers and one or more pharmaceutically acceptable excipients.2. The composition as claimed in claim 1 , wherein the composition comprises from about 10% to about 80% w/w of magnesium valproate or its pharmaceutically acceptable solvates.3. The composition as claimed in claim 1 , wherein the rate controlling polymers comprise one or more of hydrophilic polymers claim 1 , or hydrophobic polymers claim 1 , optionally an enteric polymer or mixtures thereof.4. The composition as claimed in claim 1 , wherein the rate controlling polymers comprises from about 5 to about 70% w/w of the composition.5. The composition as claimed in claim 3 , wherein the hydrophilic polymers comprise one or more of polyethylene oxides claim 3 , cellulose ethers claim 3 , polyacrylate polymers claim 3 , or mixtures thereof or other water soluble or swellable polymers.6. The composition as claimed in claim 5 , wherein the cellulose ethers comprise one or more of methylcellulose claim 5 , hydroxypropyl methyl cellulose claim 5 , hydroxypropyl ethyl cellulose claim 5 , hydroxy ethylcellulose claim 5 , hydroxypropylcellulose claim 5 , or mixtures thereof.7. The composition as claimed in claim 5 , wherein the water soluble or swellable polymers comprise one or more of sodium carboxymethyl cellulose claim 5 , locust bean gum claim 5 , xanthan gum claim 5 , acacia claim 5 , tragacanth gum claim 5 , guar gum ...

Подробнее
13-06-2013 дата публикации

Mercapto Benzophenone Compounds, Compositions and Preparation Method Thereof

Номер: US20130150479A1

The present invention provides a photocurable composition prepared using mercapto benzophenone compounds as key raw materials. The present invention aims to solve the problems existing in the prior photo-curing technology that low-molecular photoinitiators are easy to remain and migrate, while macromolecular photoinitiators has low initiation efficiency due to a low content of effective components and also has the problem of certain migration. The photocurable composition in the present invention can be easily prepared and has high addition efficiency with ethylenically unsaturated compounds, and the photocurable composition obtained by addition has no residual mercapto and has features of high initiation activity and zero migration rates when it is used in photocurable coatings, binder and ink formula. 3. The photocurable composition according to claim 2 , wherein: in the compound of said formula (I) claim 2 , R claim 2 , R claim 2 , R claim 2 , and Rare H claim 2 , and Ris methyl claim 2 , Cl claim 2 , or F; or R claim 2 , R claim 2 , R claim 2 , and Rare H claim 2 , and Ris methyl claim 2 , methoxy claim 2 , methylthio claim 2 , dimethylamino claim 2 , diethylamino claim 2 , F claim 2 , or phenyl; or R claim 2 , R claim 2 , and Rare H claim 2 , and Rand Rindependently of one another are Cl claim 2 , or methyl.43. The photocurable composition according to any one of - claims 1 , wherein component (a) is in an amount of 0.05-75% by weight relative to the total weight of said composition.53. The photocurable composition according to any one of - claims 1 , wherein component (b) includes acrylate compound claims 1 , allyl ether compound or mixture thereof.63. The photocurable composition according to any one of - claims 1 , wherein amine promotor compound can be added in said addition reaction.7. The photocurable composition according to claim 6 , wherein said amine promotor compound includes tertiary amine compound and/or active amine.8. The photocurable composition ...

Подробнее
13-06-2013 дата публикации

Antibiotic-Bound Poly(Caprolactone) Polymer

Номер: US20130150550A1
Принадлежит: UNIVERSITY OF SOUTH FLORIDA

This invention is the design and synthesis of a caprolactone monomer which bears a pendant protected carboxyl group. This monomer has been copolymerized with caprolactone in varying ratios. After polymerization, the protecting group can be removed and an antibiotic can be attached as a new pendant group. The bioactivity of the antibiotic-bound poly(caprolactone) polymer is described. This divisional application claims priority to U.S. Non-Provisional Application Ser. No. 11/746,706 filed on May 10, 2007 and U.S. Provisional Application No. 60/747,061 filed on May 11, 2006, entitled “Antibiotic-Bound Poly(Caprolactone) Polymer”.This invention was made with Government support under Grant No. RO1 A1 51351 awarded by the National Institutes of Health. The Government has certain rights in the invention.This invention relates to attaching one or more bioactive molecules to the same polymer, and also for attachment before or after polymerizationThe delivery of water-insoluble drugs to targets within the human body is a challenge that presently places strict limitations on what drugs can be applied clinically. The need for methods which overcome this is of high priority in the development of new therapeutics for treatment of human disease.The development of antibiotics for control of pathogenic bacteria has been of pressing need in this era of drug resistant infections. N-Methylthiolated b-lactams have been identified as a new family of antibacterial agents active against bacteria, including methicillin-resistant (MRSA). (See Turos, E.; Konaklieva, M. I.; Ren, R. X. F.; Shi, H.; Gonzalez, J.; Dickey, S.; Lim, D. 2000, 56, 5571; Bart Heldreth, Timothy E. Long, Seyoung Jang, Suresh K. R. Guntireddygari, Edward Turos, Sonja Dickey, Daniel V. Lim, “N-Thiolated b-Lactam Antibacterials: Effects of the N-Organothio Substituent on anti-MRSA Activity,” 14, 3775-3784 (2006); and Edward Turos, Jeung-Yeop Shim, Yang Wang, Kerriann Greenhalgh, G. Suresh Kumar Reddy, Sonja Dickey, Daniel ...

Подробнее
20-06-2013 дата публикации

Alkenyl Substituted Cycloaliphatic Compounds as Chemical Inducers of Proximity

Номер: US20130158098A1

Methods of inducing proximity of chimeric molecules in a cell are provided. Aspects of the methods include contacting a cell with an amount of alkenyl substituted cycloaliphatic (ASC) inducer compound, e.g., abscisic acid, effective to induce proximity of first and second chimeric molecules. Also provided are compositions and kits for practicing various embodiments of the methods. Methods of the invention find use in a variety of different applications, including transcription induction applications. 1. A method of inducing proximity of first and second chimeric molecules in a cell , the method comprising:contacting the cell with an amount of an alkenyl substituted cycloaliphatic (ASC) inducer compound effective to induce proximity of the first and second chimeric molecules, wherein the first and second chimeric molecules each comprise an ASC inducer domain and an effector domain.2. The method according to claim 1 , wherein the ASC inducer compound comprises a cycloaliphatic ring substituted with a hydroxyl and/or oxo group.4. The method according to claim 3 , wherein the ASC inducer compound is abscisic acid.5. The method according to claim 1 , wherein the first and second chimeric molecules are chimeric proteins.6. The method according to claim 5 , wherein the ASC inducer domain of the first chimeric protein is an ASC inducer compound specific binding domain.7. The method according to claim 6 , wherein the ASC inducer compound specific binding domain of the first chimeric protein comprises a PYR abscisic acid binding domain.8. The method according to claim 1 , wherein the effector domains of the first and second chimeric molecules are different.9. The method according to claim 1 , wherein the effector domain of the first chimeric molecule is a DNA binding domain and the effector domain of the second chimeric molecule is a transcription activation domain.10. The method according to claim 1 , wherein the effector domain of the first chimeric molecule is a cellular ...

Подробнее
20-06-2013 дата публикации

METHODS AND COMPOSITIONS FOR TREATING BRAIN CANCER

Номер: US20130158113A1
Принадлежит: GOLDEN BIOTECHNOLOGY CORPORATION

The present invention provides methods and compositions for treating brain cancer by cyclohexenone compounds. 2. The method according to claim 1 , wherein said method reduces brain cancer tumor size or tumor growth rate.3. The method of claim 1 , wherein the brain cancer is neuroblastoma claim 1 , gliomas claim 1 , meningioma claim 1 , pituitary adenoma claim 1 , acoustic neuromas claim 1 , hemangiopericytoma claim 1 , hemangioblastoma claim 1 , multiple brain metastases claim 1 , glioblastoma claim 1 , medulloblastoma claim 1 , ependymoma claim 1 , craniopharyngioma claim 1 , germinoma claim 1 , pineoblastoma claim 1 , poor prognosis malignant brain tumor claim 1 , astrocytoma claim 1 , oligodendroglioma claim 1 , relapsed brain tumor claim 1 , or progressive brain tumor.4. The method according to claim 1 , wherein said compound induces cell death in said brain cancer.6. The method according to claim 5 , wherein said cell proliferative disorder of the brain is a precancerous condition or hyperplasia or metaplasia of the brain.7. The method according to any one of claim 1 , wherein said compound claim 1 , or a pharmaceutically acceptable salt claim 1 , metabolite claim 1 , solvate or prodrug thereof claim 1 , is administered parenterally claim 1 , intravenously claim 1 , or orally.8. The method of any one of claim 1 , wherein said subject is human.10. The method of claim 9 , wherein said brain cancer cells are human brain cancer cells.11. The method of claim 9 , wherein said cyclohexenone compound prevents or inhibits migration or invasion of the brain cancer cells.12. The method of any one of claim 1 , wherein R is a hydrogen claim 1 , C(═O)CH claim 1 , C(═O)CH claim 1 , or C(═O)CH.13. The method of any one of claim 1 , wherein each of R claim 1 , Rand Rindependently is a hydrogen claim 1 , methyl claim 1 , ethyl claim 1 , propyl claim 1 , butyl claim 1 , pentyl claim 1 , hexyl claim 1 , heptyl claim 1 , or octyl.14. The method of any one of claim 13 , wherein Ris ...

Подробнее
20-06-2013 дата публикации

METHOD FOR PRODUCING METHIONINE

Номер: US20130158292A1
Автор: HAGIYA Koji, TANI Kazuyasu
Принадлежит: Sumitomo Chemical Company, Limited

A novel method capable of producing methionine without using hydrogen cyanide as a raw material has been desired. The present invention relates to a method for producing methionine including Step A of oxidizing 4-methylthio-2-oxo--butanal in the presence of an alcohol, and Step B of reductively aminating 4-methylthio-2-oxo-butyrate obtained in Step A. It is preferable that Step A is carried out by reacting 4-methylthio-2-oxo--butanal, the alcohol and an oxidizing agent in the presence of a carbene catalyst. 1. A method for producing methionine comprising:Step A of oxidizing 4-methylthio-2-oxo-1-butanal in the presence of an alcohol; andStep B of reductively aminating 4-methylthio-2-oxo-butyrate obtained in Step A.2. The production method according to claim 1 , wherein Step A is carried out by reacting 4-methylthio-2-oxo-1-butanal claim 1 , the alcohol and an oxidizing agent in the presence of a carbene catalyst.4. The production method according to claim 2 , wherein the oxidizing agent in Step A is oxygen and/or carbon dioxide.5. The production method according to claim 1 , wherein the alcohol is methanol or ethanol.6. The production method according to claim 1 , wherein Step B is carried out in the presence of a solvent.7. The production method according to claim 6 , wherein the solvent in Step B is methanol or water.8. The production method according to claim 1 , wherein Step B is carried out by reacting 4-methylthio-2-oxo-butyrate claim 1 , ammonia and a reducing agent in the presence of a transition metal.9. The production method according to claim 8 , wherein the transition metal in Step B is at least one metal selected from the group consisting of ruthenium claim 8 , rhodium claim 8 , palladium claim 8 , platinum claim 8 , iridium claim 8 , nickel claim 8 , cobalt and copper. 1. Field of the InventionThe present application is filed, claiming the Paris Convention priority based on Japanese Patent Application No. 2011-273052 (filed on Dec. 14, 2011), and the ...

Подробнее
27-06-2013 дата публикации

COMPOSITION BASED ON CERIUM, ZIRCONIUM AND TUNGSTEN, PREPARATION PROCESS AND USE IN CATALYSIS

Номер: US20130164201A1
Принадлежит:

A composition based on cerium, zirconium and tungsten is described. The composition has a content expressed as an oxide, of which cerium is from 5% to 30% of the composition, tungsten is from 2% to 17% of the composition, and the remainder of the composition is zirconium. After aging at 750° C. under an air atmosphere including 10% water, it has a two-phase crystallographic structure having a tetragonal zirconia phase and a monoclinic zirconia phase, with no presence of a crystalline phase including tungsten. The composition can be used as a catalyst, especially in an SCR process. 1. A composition comprising cerium , zirconium and tungsten , wherein the composition has the following mass contents , expressed as oxide:cerium oxide: from 5% tobctwccn 5% and 30%;tungsten oxide: from 2% tobctwccn 2% and 17%;the remainder as zirconium oxide;and in that after aging at 750° C. in an air atmosphere comprising 10% water, it has a two-phase crystallographic structure comprising a tetragonal zirconia phase and a monoclinic zirconia phase, with no presence of a crystalline phase comprising tungsten.2. The composition as defined in claim 1 , wherein after aging claim 1 , the composition has a specific surface area of at least 30 m/g.3. The composition as defined in claim 1 , wherein after aging claim 1 , the composition has a specific surface area of at least 40 m/g.4. The composition as defined in claim 1 , wherein the composition has a two-phase crystallographic structure in which the tetragonal zirconia phase and the monoclinic zirconia phase are in a ratio of at least 5.5. The process as defined in claim 1 , wherein the process is comprised of the following steps:{'sub': 2', '3, '(a) preparing an aqueous solution comprising sulfate anions and a zirconium salt, which can optionally be zirconium oxychloride, in proportions such that the ratio ZrO/SOis from 1/0.40 to 1/0.52,'}(b) cooling the solution to a temperature below 25° C.,(c) adding an alkaline compound to precipitate ...

Подробнее
27-06-2013 дата публикации

Organosulfur Compounds for the Prevention and Treatment of Neurodegenerative Diseases

Номер: US20130165515A1
Автор: Ott David Michael
Принадлежит:

Divalent salts of S-allylmercapto-N-acetylcysteine and related compositions are disclosed which can be administered in order to provide protection from the formation of aldehyde-protein adducts, protein carbonylation, protein aggregation, and the resulting neuroinflammation. Various neurodegenerative diseases which are suitable for treatment using these compositions include Alzheimer's disease, senile dementia, Parkinson's disease, multiple sclerosis, Lewy body disease, peripheral neuropathy, spinal cord injury, stroke and cerebral ischemia. 1. A method of treating a neurodegenerative disease or condition selected from the group of(a) the condition of amyloid-beta plaque formation that is associated with the development and progression of senile dementia or Alzheimer's disease,(b) the condition of Lewy body formation that is associated with the development and progression of Lewy body disease or Parkinson's disease,(c) the condition of carbonylation of proteins within the brain that is associated with the development and progression of Alzheimer's or Parkinson's Disease,(d) the condition of neurofibrillary tangle formation that is associated with tauopathies and Alzheimer's disease'(e) the condition of neuronal demylenation that is associated with the development and progression of peripheral neuropathy, spinal cord injury, or the disease of multiple sclerosis.(f) the condition of aldehyde mediated protein damage that is associated with the immediate recovery from stroke and cerebral ischemia and their subsequent progression,said method comprising:administering to an animal in need thereof an organosulfur composition comprising an effective amount of the mixed disulfide of a lipophilic mercaptan disulfide bonded to N-acetylcysteine further bonded as a two to one salt with a divalent cation;said lipophilic mercaptan being constrained to have a linear or branched carbon backbone, a single sulfur atom, and a molecular mass of 200 g/mol or less;wherein said lipophilic ...

Подробнее
27-06-2013 дата публикации

Method of Bowel Cleansing

Номер: US20130165519A1
Автор: SNADY HARRY
Принадлежит:

A method is disclosed for cleansing bowels prior to a colonic procedure utilizing conventional preparations along with potatoes or potato-constituents or potato-substitutes. 1. A method of cleansing bowels in a patient a day prior to a colonic procedure , and refraining from consuming all fluids approximately four hours prior to said procedure , comprising the steps:a. wherein said patient consumes only clear fluids, except for potatoes at breakfast;b. wherein said patient drinks at least 64 fluid ounces of clear fluids throughout said day;c. wherein said patient drinks approximately 10 fluid ounces of magnesium citrate between 1 p.m. and 5 p.m. on said day;d. wherein said patient drinks between 25 and 33 grams of polyethylene-glycol approximately two hours after the magnesium citrate;e. wherein said patient drinks approximately 8 fluid ounces of water or clear fluid about ten minutes after the polyethylene-glycol;f. wherein said patient drinks approximately 10 fluid ounces of magnesium citrate between two or three hours after the water or clear fluid;g. wherein said patient drinks another 25 to 33 grams of polyethylene -glycol at a time between four to eight hours prior to said procedure; andh. said patient refrains from consuming all fluids approximately four hours prior to said procedure.2. A method of cleansing bowels in a patient a day prior to a colonic procedure , and refraining from consuming all fluids approximately four hours prior to said procedure , comprising the steps:a. wherein said patient consumes only clear fluids, except for potato-constituents at breakfast;b. wherein said patient drinks at least 64 fluid ounces of clear fluids throughout said day;c. wherein said patient drinks approximately 10 fluid ounces of magnesium citrate between 1 p.m. and 5 p.m. on said day;d. wherein said patient drinks between 25 and 33 grams of polyethylene-glycol approximately two hours after the magnesium citrate;e. wherein said patient drinks approximately 8 fluid ...

Подробнее
27-06-2013 дата публикации

TREATMENT OF FUNGAL INFECTIONS

Номер: US20130165521A1
Автор: Agholme Astrid
Принадлежит: ABBELL AB

The present disclosure relates to compositions comprising formic acid as an active ingredient and a softening agent or emollient for use in the treatment of fungal infections of the skin and/or nail(s) of mammals, as well as methods for treatment utilizing such compositions. 118-. (canceled)19. Method for treatment of fungal infections of the skin and/or nail(s) of a mammal by administration of a composition comprising formic acid as an active ingredient and softening agent or emollient.20. Method according to for treatment of fungal infections of the nail(s) (tinea unguium).21. Method according to for treatment of fungal infections of the skin.22. Method according to claim 21 , wherein the infections of the skin represent Athlete's foot.23. Method according to claim 19 , wherein the concentration of formic acid is within the range of from 10 to 90% by weight.24. Method according to claim 23 , wherein the concentration of formic acid is within the range of from 20 to 80% by weight.25. Method according to claim 24 , wherein the concentration of formic acid is within the range of from 30 to 70% by weight.26. Method according to claim 25 , wherein the concentration of formic acid is within the range of from 40 to 60% by weight.27. Method according to claim 26 , wherein the concentration of formic acid is 50% by weight.28. Method according to claim 19 , wherein the softening agent or emollient is selected from propylene glycol claim 19 , glycerol claim 19 , glyceryl triacetate claim 19 , lactic acid claim 19 , sorbite claim 19 , isopropyl myristate claim 19 , isopropyl palmitate claim 19 , urea claim 19 , stearic acid claim 19 , stearyl alcohol cocoglycerides claim 19 , octyldodecanol claim 19 , diisopropyl adipate claim 19 , cetearyl octanoate claim 19 , isohexadecanol claim 19 , diisopropyl adipate claim 19 , isopropyl stearate claim 19 , isopropyl laurate and 2-ethylhexyl oxystearate.29. Method according to claim 28 , wherein the softening agent or emollient is ...

Подробнее
27-06-2013 дата публикации

CO-PRODUCTION OF BIOFUELS AND GLYCOLS

Номер: US20130165698A1
Автор: POWELL Joseph Broun
Принадлежит: SHELL OIL COMPANY

Methods and systems for co-producing higher hydrocarbons and glycols from bio-based feedstocks containing carbohydrates are disclosed. 1. A method comprising:(i) providing a bio-based feedstock stream containing carbohydrates and water;(ii) contacting, in a first reaction system, the bio-based feedstock stream with an aqueous phase reforming catalyst at a temperature in the range of 120° C. to 280° C. and 0.1 to 150 bar of hydrogen to form a first intermediate stream containing plurality of oxygenated intermediates comprising at least 5 wt %, based on the total oxygenates content, of glycols that comprises ethylene glycol (EG) and 1,2-propylene glycol (PG), and other monooxygenates;(iii) contacting, in a second reaction system, at least a first portion of said first intermediate stream in the presence of a aqueous phase reforming catalyst at a temperature in the range of 160° C. to 280° C. to produce a second intermediate stream containing plurality of oxygenated intermediates stream and hydrogen;(iv) providing at least a portion of said hydrogen to the first reaction system;(v) processing at least a portion of the second intermediate stream to form a liquid fuel;(vi) providing a second portion of said first intermediate stream to a first separation system;(vii) separating a portion of said first intermediate stream, in the first separation system, to a monooxygenates stream comprising monooxygenates and a glycol rich stream comprising at least 10 wt %, based on the total oxygenates, of glycols by flashing; and(viii) recovering glycols from the glycol rich stream.2. The method of wherein further comprising (ix) recycling at least a portion of said monooxygenates stream to the first reaction system.3. The method of wherein glycols are recovered by separating finished glycol from the glycol rich stream.4. The method of wherein the glycol content of the first intermediate stream produced in step (ii) is at least 25 wt % claim 1 , based on the total oxygenates content.5 ...

Подробнее
04-07-2013 дата публикации

METHOD FOR INCREASING PLANT YIELD, AND YIELD IMPROVING COMPOSITIONS

Номер: US20130172185A1
Автор: Wei Zhongmin
Принадлежит: PLANT HEALTHCARE, INC.

The present invention relates to a method of increasing yield of a plant. This method involves applying to a plant and/or area of cultivation thiophanate methyl and an isolated hypersensitive response elicitor protein or polypeptide fragment, wherein said applying is carried out under conditions effective to induce a synergistic yield from the plant. The present invention also relates to a composition comprising a liquid or solid carrier, thiophanate methyl, and an isolated hypersensitive response elicitor protein or polypeptide fragment. 1. A method of increasing yield of a plant , said method comprising:applying to a plant and/or area of cultivation thiophanate methyl and an isolated hypersensitive response elicitor protein or polypeptide fragment, wherein said applying is carried out under conditions effective to induce a synergistic yield from the plant.2. The method according to claim 1 , wherein yield is selected from improved plant vigor claim 1 , increased tolerance or resistance to biotic and/or abiotic stress claim 1 , increased plant weight claim 1 , increased biomass claim 1 , increased number of flowers per plant claim 1 , higher grain and/or fruit yield claim 1 , more tillers or side shoots claim 1 , larger leaves claim 1 , increased shoot growth claim 1 , increased protein content claim 1 , increased oil content claim 1 , increased starch content claim 1 , increased pigment content claim 1 , increased chlorophyll content claim 1 , and combinations thereof.3. The method according to claim 1 , wherein the plant is dry bean and yield is increased by at least about 23%.4. The method according to claim 1 , wherein the plant is peanut and yield is increased by at least about 3%.5. The method according to claim 1 , wherein thiophanate methyl and an isolated hypersensitive response elicitor protein or polypeptide fragment are applied as a single composition.6. The method according to claim 1 , wherein thiophanate methyl and an isolated hypersensitive response ...

Подробнее
04-07-2013 дата публикации

PROCESS FOR PREPARATION OF HIV PROTEASE INHIBITORS

Номер: US20130172295A1
Принадлежит: Gilead Sciences, Inc.

A process for the synthesis of bisfuran intermediates useful for preparing antiviral HIV protease inhibitor compounds is hereby disclosed 4. The process of claim 1 , where the reaction is carried out at a temperature of between about 0° C. to about 100° C.5. The process of claim 1 , where the reaction is carried out in the presence of a catalyst comprising a lanthanide or transition metal complexed to a chiral ligand.7. The process of claim 1 , which is carried out in the presence of a solvent.8. The process of claim 7 , where the solvent is a polar aprotic solvent.9. The process of claim 8 , where the solvent is methyl-t-butyl-ether claim 8 , dichloromethane or a mixture thereof.10. The process of claim 1 , which is carried out in the presence of excess 2 claim 1 ,3-dihydrofuran as a solvent.11. The process of claim 1 , where the catalyst comprises Sc.12. The process of claim 1 , where the catalyst comprises Yb.18. The process of claim 17 , where the deprotection is accomplished by combining the compound of Formula M with a deprotecting agent which is selected from trifluoroacetic acid claim 17 , hydrochloric acid claim 17 , toluenesulfonic acid claim 17 , methanesulfonic acid claim 17 , benzenesulfonic acid claim 17 , or hydrobromic acid.20. The process of claim 19 , where the reduction is accomplished by contacting the compound of Formula C with a reducing agent which is lithium aluminum hydride claim 19 , sodium borohydride claim 19 , lithium borohydride claim 19 , sodium trisacetoxyborohydride claim 19 , sodium cyanoborohydride claim 19 , potassium triisopropoxy borohydride or diisobutyl aluminum hydride28. A pharmaceutical composition comprising the salt of and an excipient claim 27 , diluent or carrier.29. A method for the treatment or prophylaxis of a retrovirus infection in a patient claim 27 , comprising administering to the patient a therapeutically effective amount of the salt of .30. The method of claim 29 , where the retrovirus is human ...

Подробнее
04-07-2013 дата публикации

SULFUR-CONTAINING COMPOUND, METHOD OF PREPARATION AND PHARMACEUTICAL USES THEREOF

Номер: US20130172355A1
Принадлежит: NATIONAL SUN YAT-SEN UNIVERSITY

The invention relates to a sulfur-containing compound and the preparation thereof. The invention also relates to the uses of the sulfur-containing compound in inhibiting inducible nitric oxide synthase and/or cyclooxygenase-2 and in treating the diseases associated with inducible nitric oxide synthase and/or cyclooxygenase-2. This invention also describes a series of chemical analogues of the said sulfur-containing compound and the preparation of these compounds. 2. The method according to claim 1 , wherein Ris selected from the group consisting of methyl claim 1 , ethyl claim 1 , and unsubstituted phenyl.6. The method according to claim 5 , wherein Ris selected from the group consisting of methyl claim 5 , ethyl claim 5 , and unsubstituted phenyl.9. The method according to claim 5 , wherein the disease is selected from the group consisting of inflammation claim 5 , atherosclerosis claim 5 , neuropathic pain claim 5 , inflammatory neointimal proliferation claim 5 , arthritis claim 5 , multiple sclerosis claim 5 , inflammatory pain claim 5 , and spinal cord injury.10. The method according to claim 5 , wherein the compound is administered by injection. This application is a Divisional of the pending U.S. patent application Ser. No. 12/172,633 filed on Jul. 14, 2008, all of which is hereby incorporated by reference in its entirety.Although incorporated by reference in its entirety, no arguments or disclaimers made in the parent application apply to this divisional application. Any disclaimer that may have occurred during the prosecution of the above-referenced application(s) is hereby expressly rescinded. Consequently, the Patent Office is asked to review the new set of claims in view of the entire prior art of record and any search that the Office deems appropriate.1. Field of the InventionThe invention relates to a novel sulfur-containing compound. Said sulfur-containing compound has ability to inhibit the function of inducible nitric oxide synthase (iNOS) and/or ...

Подробнее
04-07-2013 дата публикации

NOVEL CANNABINOID RECEPTOR 2 (CB2) INVERSE AGONISTS AND THERAPEUTIC POTENTIAL FOR MULTIPLE MYELOMA AND OSTEOPOROSIS BONE DISEASES

Номер: US20130172388A1

Cannabionid receptor-2 inverse antagonists include compounds represented by Formula IV, or a pharmaceutically acceptable salt thereof: 3. The compound according to claim 2 , wherein R′″ is (C-C)heterocycloalkyl.4. The compound according to claim 3 , wherein R′″ is oxetanyl claim 3 , tetrahydrofuranyl claim 3 , tetrahydropyranyl claim 3 , oxepanyl claim 3 , tetrahydrothiophenyl claim 3 , tetrahydrothiopyranyl claim 3 , 1 claim 3 ,3-dioxanyl claim 3 , oxazolidinyl claim 3 , azetidinyl claim 3 , pyrrolidinyl claim 3 , piperidinyl claim 3 , azepinyl claim 3 , piperazinyl claim 3 , morpholinyl claim 3 , tetrahydrothiopyranyl-1-oxide claim 3 , tetrahydrothiopyranyl-1 claim 3 ,1-dioxide claim 3 , pyrrolidinonyl claim 3 , piperidinonyl claim 3 , azepinonyl claim 3 , piperazidinonyl claim 3 , oxazidilinonyl claim 3 , azetidinonyl claim 3 , or morpholinonyl.7. (canceled)8. The compound according to claim 1 , wherein the compound conforms to Formula I′ and whereinD is H;D′ is phenyl;{'sub': 1', '6, 'B and Q are independently (C-C)alkylene;'}e is 0 and each of f and g is 1; and{'sup': a′', 'a″', 'a′″, 'sub': 1', '6, 'each of R, R, and R is independently selected from the group consisting of H, and straight or branched chain (C-C)alkyl.'}10. (canceled)12. The compound according to claim 11 , wherein subscripts h and k independently are 0 and subscript j is 1.14. (canceled)16. The compound according to claim 15 , wherein substituent X is N claim 15 , T and R are each independently S(O)— and Q′ is (C-C)alkyl.17. The compound according to claim 15 , wherein substituent X is CH— and each of Q′ claim 15 , R and T are independently —O—(CH)—O— claim 15 , —OC(O)— or (CH)—OC(O)—.2022-. (canceled)23. A pharmaceutical composition comprising a therapeutically effective amount of a compound according to claim 1 , or a pharmaceutically acceptable salt thereof; and a pharmaceutically acceptable carrier.24. (canceled)25. A method for treating multiple myeloma or osteoporosis in a subject by ...

Подробнее
04-07-2013 дата публикации

3-METHANESULFONYLPROPIONITRILE FOR TREATING INFLAMMATION AND PAIN

Номер: US20130172410A1
Автор: St. Laurent Joseph
Принадлежит: OLATEC INDUSTRIES LLC

The present invention relates to purified 3-methanesulfonylpropionitrile or a pharmaceutically acceptable salt thereof, and a method for preparing such compound. The compound has at least 90% (w/w) purity. The present invention is also directed to a pharmaceutical composition comprises the purified compound and a pharmaceutically acceptable carrier. The present invention is further directed to a method for treating inflammation, inflammatory-related disorders, or pain, by administering 3-methanesulfonylpropionitrile or a pharmaceutically acceptable salt or solvate thereof to a subject in need thereof. 1. A method of treating inflammation , comprising the steps of:identifying a subject suffering from inflammation, andadministering to the subject a compound of 3-methanesulfonylpropionitrile, or a pharmaceutically acceptable salt or solvate thereof, in an amount effective to treat inflammation.2. The method according to claim 1 , wherein said method reduces or alleviates the symptoms of localized manifestations of inflammation characterized by acute or chronic swelling claim 1 , pain claim 1 , or redness.3. The method according to claim 1 , wherein said compound is administered by a local administration.4. The method according to claim 3 , wherein said compound is administered in a topical form of gel claim 3 , cream claim 3 , lotion claim 3 , liquid claim 3 , emulsion claim 3 , ointment claim 3 , spray claim 3 , solution claim 3 , suspension claim 3 , or patch.5. The method according to claim 4 , wherein said compound is in an amount of about 0.5-10% (w/w) in the topical form.6. The method according to claim 5 , wherein topical form comprises diethyleneglycol monoethylether.7. The method according to claim 1 , wherein said 3-methanesulfonylpropionitrile is administered by a systemic administration.8. The method according to claim 7 , wherein said 3-methane sulfonylpropionitrile is administered in an oral form of tablets claim 7 , capsules claim 7 , granules claim 7 , ...

Подробнее
04-07-2013 дата публикации

METHOD FOR PREPARING A COMPLEX OF AN ACID AND A METAL

Номер: US20130172617A1
Принадлежит: ADISSEO IRELAND LIMITED

The invention concerns a method for preparing a complex of an acid chosen from among methionine, 2-hydroxy-4-methylthiobutanoic acid (HMTBA) and lactic acid, and of at least one metal, starting from said acid and a mineral metal source, wherein the acid is caused to react with the mineral metal source in an extruder. 1. A method for preparing a complex of an acid chosen from among methionine , 2-hydroxy-4-methylthiobutanoic acid (HMTBA) and lactic acid , and of at least one metal , starting from the said acid and a mineral metal source , characterized in that the acid is placed in reaction with the mineral metal source in an extruder.2. The method according to claim 1 , wherein the metal is chosen from among Li claim 1 , Na claim 1 , K claim 1 , Mg claim 1 , Ca claim 1 , Mn claim 1 , Fe claim 1 , Co claim 1 , Ni claim 1 , Cu claim 1 , Zn claim 1 , Pt.3. The method according to claim 1 , wherein the mineral metal source is chosen from among metallic hydroxides claim 1 , metallic hydroxide milks claim 1 , metallic oxides and corresponding metallic carbonates claim 1 , whether or not of natural origin.4. The method according to claim 3 , wherein the mineral metal source is of natural origin and is chosen from among shells claim 3 , ores and rocks.5. The method according to claim 1 , wherein the acid is 2-hydroxy-4-methylthiobutanoic acid (HMTBA) and the metal is calcium claim 1 , the calcium source being chosen from among lime claim 1 , milk of lime claim 1 , slaked lime claim 1 , calcium hydrogen carbonate and calcium carbonate.6. The method according to wherein the mineral metal source is chosen from among oyster shell claim 5 , snail shell claim 5 , dolomite.7. The method according to claim 3 , wherein the calcium source is Ca(OH).8. The method according to claim 1 , wherein the acid is methionine or 2-hydroxy-4-methylthiobutanoic acid (HMTBA) and a metal is chosen from among zinc claim 1 , manganese and copper claim 1 , the metal source being chosen from among the ...

Подробнее
11-07-2013 дата публикации

SULFOXIDE-BASED SURFACTANTS

Номер: US20130178540A1
Принадлежит:

The present invention provides sulfoxide compounds comprising hydrophobic ester or amide moieties such that the compounds have surfactant properties. Also provided are methods for using the sulfoxide compounds or mixtures of the sulfoxide compounds in a variety of applications. 2. The compound of claim 1 , wherein Ris alkyl; Ris alkyl claim 1 , acyl claim 1 , (CHCHO)H claim 1 , (CHCH(CH)O)H claim 1 , or a combination of (CHCHO)H and (CHCH(CH)O)H; p is an integer of 2 or greater; and Ris Cto Calkyl.3. The compound of claim 2 , wherein n is 2; Ris methyl; Ris NHor NHR; and Ris Cto Calkyl.5. The compound of claim 4 , wherein Ris alkyl; Ris hydrogen claim 4 , alkyl claim 4 , acyl claim 4 , (CHCHO)H claim 4 , (CHCH(CH)O)H claim 4 , or a combination of (CHCHO)H and (CHCH(CH)O)H; p is an integer of 2 or greater; and Ris Cto Calkyl.6. The compound of claim 5 , wherein n is 2; Ris methyl; and Ris Cto Calkyl.7. The compound of claim 1 , wherein the compound has a critical micelle concentration (CMC) in water at 25° C. and atmospheric pressure.8. The compound of claim 1 , wherein the compound is used in commercial or residential laundry products claim 1 , industrial or household cleaning products claim 1 , floor polishing products claim 1 , personal care or cosmetic products claim 1 , textile processing claim 1 , metal processing claim 1 , paper processing claim 1 , agricultural applications claim 1 , latex production claim 1 , paper de-inking claim 1 , or crude oil drilling applications.10. The compound of claim 9 , wherein Ris alkyl; Ris hydrogen claim 9 , alkyl claim 9 , acyl claim 9 , (CHCHO)H claim 9 , (CHCH(CH)O)H claim 9 , or a combination of (CHCHO)H and (CHCH(CH)O)H; p is an integer of 2 or greater; and Ris Cto Calkyl.11. The compound of claim 10 , wherein n is 2 claim 10 , k is 1 claim 10 , 2 claim 10 , 3 claim 10 , or 4; Ris methyl; Ris hydrogen; Ris Cto Calkyl; and W and X are oxygen.12. The compound of claim 9 , wherein the compound has a critical micelle ...

Подробнее
18-07-2013 дата публикации

METHOD FOR PREPARING AN AMINO ACID FROM 2 AMINOBUTYROLACTONE

Номер: US20130184474A1
Принадлежит: ADISSEO FRANCE S.A.S.

The invention relates to a method for preparing an amino acid, or its salts, from 2-aminobutyrolactone (2ABL), said amino acid fitting the formula I, XCHCHCHNHCOOH, wherein X is such that X represents a nucleophilic ion, according to which N-carboxylation of 2-aminobutyrolactone (2ABL) is achieved with carbon dioxide, and the thereby obtained 2ABL carbamate is reactive with an XH reagent or its salts. 1. A method for preparing an amino acid , or its salts , from 2-aminobutyrolactone (2ABL) , said amino acid fitting the formula I , XCHCHCHNHCOOH , wherein X is such that X represents a nucleophilic ion , characterized in that it comprises the following steps:N-carboxylation of 2-aminobutyrolactone (2ABL) is achieved with carbon dioxide, andthe N-carboxyl of the thereby obtained 2ABL is reacted with a reagent XH or its salts and acidification is performed.2. The method according to claim 1 , characterized in that X is selected from CHS claim 1 , CHSe claim 1 , SH claim 1 , SeH claim 1 , CN.3. The method according to claim 1 , characterized in that an amino acid selected from methionine and selenomethionine.4. The method according to claim 1 , characterized in that homocysteine and its dimer are obtained.5. The method according to claim 1 , characterized in that N-carboxylation is carried out in an aprotic polar solvent.6. The method according to claim 5 , characterized in that the solvent is selected from dimethylsulfoxide and N-methylpyrrolidone.7. The method according to claim 1 , characterized in that the L isomer of the amino acid claim 1 , the D isomer or mixtures of the latter and notably the racemic mixture are prepared from the corresponding form of 2ABL.8. The method according to claim 1 , characterized in that 2ABL is obtained from homoserine.9. The method according to claim 8 , characterized in that homoserine is the L isomer and is obtained by microbiological fermentation of sugars of natural origin.10. The method according to claim 1 , characterized in ...

Подробнее
25-07-2013 дата публикации

CATALYST FOR REMOVING NITROGEN OXIDES FROM THE EXHAUST GAS OF DIESEL ENGINES

Номер: US20130189172A1
Принадлежит: UMICORE AG & CO. KG

The invention relates to a catalyst for removal of nitrogen oxides from the exhaust gas of diesel engines, and to a process for reducing the level of nitrogen oxides in the exhaust gas of diesel engines. The catalyst consists of a support body of length L and of a catalytically active coating which in turn may be formed from one or more material zones. The material zones comprise selectively catalytically reductive (SCR-active) mixed oxide consisting of cerium oxide, zirconium oxide, rare earth sesquioxide and niobium oxide and optionally tungsten oxide. In addition, the material zones comprise at least one compound selected from the group consisting of barium oxide, barium hydroxide, barium carbonate, strontium oxide, strontium hydroxide, strontium carbonate, praseodymium oxide, lanthanum oxide, magnesium oxide, mixed magnesium/aluminum oxide, alkali metal oxide, alkali metal hydroxide, alkali metal carbonate and mixtures thereof. Noble metal may optionally also be present in the catalyst. 1. A catalyst for removing nitrogen oxides from the exhaust gas of diesel engines , consisting of a support body of length L and a catalytically active coating composed of one or more material zones comprisinga) a catalytically active mixed oxide consisting of cerium oxide, zirconium oxide, rare earth sesquioxide and niobium oxide and optionally tungsten oxide; andb) at least one compound selected from the group consisting of barium oxide, barium hydroxide, barium carbonate, strontium oxide, strontium hydroxide, strontium carbonate, praseodymium oxide, lanthanum oxide, magnesium oxide, mixed magnesium/aluminum oxide, alkali metal oxide, alkali metal hydroxide, alkali metal carbonate and mixtures thereof.2. The catalyst as claimed in claim 1 , wherein the catalytically active mixed oxide claim 1 , based on the total amount thereof claim 1 , has the following composition:{'sub': '2', 'CeO: 15-50% by wt.'}{'sub': 2', '5, 'NbO: 3-25% by wt.'}{'sub': 2', '3, 'REO: 3-10% by wt.'}{'sub ...

Подробнее
25-07-2013 дата публикации

SAXAGLIPTIN PHARMACEUTICAL FORMULATIONS

Номер: US20130189358A1
Принадлежит:

The present invention includes a compressed solid dosage form comprising saxagliptin or a pharmaceutically acceptable salt thereof and at least one pharmaceutically acceptable excipient, wherein the at least one pharmaceutically acceptable excipient optionally comprises at least one organic acid. 1. A compressed solid dosage form comprising saxagliptin or a pharmaceutically acceptable salt thereof and at least one pharmaceutically acceptable excipient.2. A dosage form according to claim 1 , wherein the at least one pharmaceutically acceptable excipient comprises at least one organic acid claim 1 , filler claim 1 , disintegrant claim 1 , lubricant claim 1 , binder claim 1 , or a mixture thereof.3. A dosage form according to claim 2 , wherein the at least one pharmaceutically acceptable excipient comprises at least one organic acid claim 2 , filler claim 2 , disintegrant claim 2 , lubricant claim 2 , or a mixture thereof.4. A dosage form according to claim 1 , wherein the at least one pharmaceutical comprises at least one organic acid.5. A dosage form according to claim 4 , wherein the pharmaceutically acceptable excipient further comprises a filler claim 4 , disintegrant and lubricant.6. A dosage form according to claim 2 , wherein the filler is microcrystalline cellulose claim 2 , sorbitol claim 2 , dextrose claim 2 , sucrose claim 2 , mannitol claim 2 , dibasic calcium phosphate claim 2 , starch claim 2 , or mixtures thereof.7. A dosage form according to claim 6 , wherein the filler is microcrystalline cellulose claim 6 , sorbitol claim 6 , dextrose claim 6 , sucrose claim 6 , mannitol claim 6 , or a mixture thereof.8. A dosage form according to claim 7 , wherein the filler is mannitol.9. A dosage form according to claim 2 , wherein the filler is present in an amount of about 60 to about 90 wt %.10. A dosage form according to claim 9 , wherein the filler is present in an amount of about 70 to about 82 wt %.11. A dosage form according to claim 4 , wherein the at ...

Подробнее
25-07-2013 дата публикации

Pesticidal Treatment Compositions

Номер: US20130190178A1

The pesticidal compositions comprising synergistic mixtures of O,O-dimethyl S-phthalimidomethyl phosphorodithioate or suitable salt forms thereof, and at least one benzoylurea based chitin inhibiting compound or suitable salt forms thereof, and especially preferably one or more of (RS)-1-[3-chloro-4-(1,1,2-trifluoro-2-trifluoromethoxyethoxy)phenyl]-3-(2,6-di-fluorobenzoyl)urea (also interchangeably referred to as “novaluron”) or suitable salt forms thereof, and 1-(2-chlorobenzoyl)-3-(4-trifluoromethoxyphenyl)urea (also interchangeably referred to as “triflumuron”) or suitable salt forms thereof, for the control of undesired pests, preferably for the control of Codling moths in fruit. Methods of controlling the incidence of undesired pests, via treatment regimens providing synergistic amounts of each of the foregoing compounds, are also disclosed. 1. Pesticidal compositions comprising synergistic mixtures of O ,O-dimethyl S-phthalimidomethyl phosphorodithioate or suitable salt forms thereof , and at least one benzoylurea based chitin inhibiting compound or suitable salt forms thereof , and especially preferably one or more of (RS)-1-[3-chloro-4-(1 ,1 ,2-trifluoro-2-trifluoromethoxyethoxy)phenyl]-3-(2 ,6-difluorobenzoyl)urea (also interchangeably referred to as “novaluron”) or suitable salt forms thereof , and 1-(2-chlorobenzoyl)-3-(4-trifluoromethoxyphenyl)urea (also interchangeably referred to as “triflumuron”) or suitable salt forms thereof , for the control of undesired insect pests.2. Pesticidal compositions according to claim 1 , wherein the undesired insect pests are Codling moth in one or more stages of its growth.3. A method for controlling undesired insect pests in crops claim 1 , the method comprising the step of:{'claim-ref': {'@idref': 'CLM-00001', 'claim 1'}, 'applying a pesticidal composition according to to the crop, in an effective amount in order to control the insect pest.'}4. The method for controlling the incidence of Codling moth in one or more ...

Подробнее
25-07-2013 дата публикации

SULFUR DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS

Номер: US20130190338A1
Принадлежит: ALLERGAN, INC.

The present invention relates to novel sulfur derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of chemokine receptors. 2. A compound according to claim 1 , wherein:{'sup': '5', 'Ris S.'}3. A compound according to claim 1 , wherein:{'sup': '5', 'Ris —S(O)—.'}4. A compound according to claim 1 , wherein:{'sup': '5', 'sub': '2', 'Ris —S(O)—.'}5. A compound according to claim 1 , wherein:{'sup': '1', 'Ris H;'}{'sup': '2', 'sub': 1-6', '3-8', '3-8, 'Ris substituted or unsubstituted Calkyl, substituted or unsubstituted Ccycloalkyl or substituted or unsubstituted Ccycloalkenyl;'}{'sup': '5', 'sub': '2', 'Ris —S—, —S(O)—, or —S(O)—;'}{'sup': '6', 'Ris optionally substituted 1-benzofuran;'}{'sup': '17', 'sub': '1-6', 'Ris H, substituted or unsubstituted Calkyl or halogen;'}{'sup': '18', 'sub': '1-6', 'Ris H, substituted or unsubstituted Calkyl or halogen;'}{'sup': '7', 'sub': 1-6', '1-6', '3-8, 'Ris H, halogen, CN, —OCalkyl, substituted or unsubstituted Calkyl or substituted or unsubstituted Ccycloalkyl; and'}{'sup': '8', 'sub': '1-6', 'Ris H, substituted or unsubstituted Calkyl, CN or halogen.'}6. A compound according to claim 5 , wherein:{'sup': '1', 'Ris H;'}{'sup': '2', 'sub': '1-6', 'Ris substituted or unsubstituted Calkyl;'}{'sup': '5', 'sub': '2', 'Ris —S—, —S(O)—, or —S(O)—;'}{'sup': '6', 'Ris optionally substituted 1-benzofuran;'}{'sup': '17', 'Ris H;'}{'sup': '18', 'Ris H;'}{'sup': '7', 'sub': '1-6', 'Ris H, halogen or Calkyl; and'}{'sup': '8', 'Ris H or CN.'}7. A compound according to claim 6 , wherein:{'sup': '1', 'Ris H;'}{'sup': '2', 'Ris methyl propionate, methyl-2-benzoic acid, methyl-2-methylbenzoate, methyl-3-methylphenylacetamide, methyl-3-methylphenylsulfonamide, methyl acetic acid, methyl-2-methylphenylcarboxylate or propionic acid;'}{'sup': '5', 'sub': '2', 'Ris —S(O)—, S or —S(O)—;'}{'sup': '6', 'Ris optionally substituted 1-benzofuran;'}{'sup': '7', 'Ris chlorine, ...

Подробнее
25-07-2013 дата публикации

Novel Tetrahydronaphalene Antagonists to the Thromboxane A2 (TP) Receptor

Номер: US20130190370A1

The present invention relates to TP receptor antagonists, which have the ability to bind to TP receptor and optionally cross the blood brain barrier. The invention also provides compositions and methods for treating a disorder wherein activation of TP receptor is detrimental. 1. A composition comprising a TP receptor antagonist , wherein said antagonist comprises the chemical structures set forth in , a salt thereof , a prodrug thereof , and combinations thereof.2. The composition of claim 1 , wherein said antagonist binds to a TP receptor or a TP-like receptor.3. The composition of claim 1 , wherein said antagonist inhibits activation of a TP receptor or a TP-like receptor.4. The composition of claim 1 , wherein said antagonist is able to cross the blood brain barrier of a mammal.5. The composition of claim 1 , wherein said antagonist is not able to cross the blood brain barrier of a mammal.6. The composition of claim 1 , wherein said antagonist is selected from the group consisting of CNDR-51418 claim 1 , CNDR-51281 claim 1 , CNDR-51354 and CNDR-51414.7. A method of treating a disorder associated with activation of a TP receptor in a mammal in need thereof claim 1 , said method comprising administering to said mammal a therapeutically effective amount of a compound claim 1 , wherein said compound comprises a TP receptor antagonist claim 1 , wherein said antagonist comprises the chemical structures set forth in claim 1 , a salt thereof claim 1 , a prodrug thereof claim 1 , and combinations thereof.8. The method of claim 7 , wherein said antagonist is able to cross the blood brain barrier of said mammal.9. The method of claim 7 , wherein said antagonist is not able to cross the blood brain barrier of said mammal.10. The method of claim 7 , wherein said mammal is a human.11. The method of claim 7 , wherein said disorder associated with activation of a TP receptor is a neurodegenerative disorder.12. The method of claim 11 , wherein said neurodegenerative disorder is ...

Подробнее
25-07-2013 дата публикации

NOVEL SULFONAMIDE COMPOUNDS FOR INHIBITION OF METASTATIC TUMOR GROWTH

Номер: US20130190396A1
Принадлежит: METASIGNAL THERAPEUTICS INC.

Therapeutic ureido-sulfonamide compositions having compounds with the formula 1. A pharmaceutical composition comprising a pharmaceutically acceptable excipient and a compound of Formula (I){'br': None, 'sub': 2', '2, 'R-Q-Ar—SONH\u2003\u2003Formula (I)'}wherein,R is an aryl, heteroaryl, aralkyl, alkyl or cycloalkyl group, with or without a substituent;{'sub': 2', 'n, 'Q is -L(CH)—, wherein n=0, 1 or 2;'}{'sub': '2', 'L is —NHC(X)NH—, —NHC(S)SNH—, —NHC(O)NHC(S)NH—, or —SONH—;'}X is O or S; and{'sub': 6', '10, 'Ar is a C-Caryl or a heteroaryl that contains at least one heteroatom of oxygen, nitrogen or sulphur, provided that the compound of Formula (I) is not'}4-[(anilinocarbonyl)amino]benzenesulfonamide;4-{[(Pentafluorophenyl)carbamoyl]amino}benzenesulfonamide;4-{[(4′-Acetylphenyl)carbamoyl]amino}benzenesulfonamide;4-{[(4′-Chlorophenyl)carbamoyl]amino}benzenesulfonamide; or4-{[([4′-(Trifluoromethyl)phenyl]aminocarbonyl)amino]}benzenesulfonamide.2. The pharmaceutical composition of wherein Q is —NHC(O)NH— claim 1 , Ar is phenyl claim 1 , and R is PhCH claim 1 , PhCH claim 1 , 4-FCH claim 1 , 4-ClCH claim 1 , 4-BrCH claim 1 , CF claim 1 , 2-MeOCH claim 1 , 4-AcCH claim 1 , 2-i-PrCH claim 1 , 4-i-PrCH claim 1 , 4-n-BuCH claim 1 , 4-n-BuOCH claim 1 , 4-n-octyl-CH claim 1 , 4-NCCH claim 1 , 2-NCCH claim 1 , 4-PhOCH claim 1 , 2-PhCH claim 1 , 3-ONCH claim 1 , 4-MeO-2-MeCH claim 1 , Cyclopentyl claim 1 , Indan-5-yl claim 1 , 3 claim 1 ,5-MeCH claim 1 , 4-CFCH claim 1 , or 3 claim 1 ,5-(CF)CH.3. The pharmaceutical composition of wherein the compound of Formula (I) is4-{[(Benzylamino)carbonyl]amino}benzenesulfonamide;4-{[(Benzhydrylamino)carbonyl]amino}benzenesulfonamide;4-{[(4′-Fluorophenyl)carbamoyl]amino}benzenesulfonamide;4-{[(4′-Bromophenyl)carbamoyl]amino}benzenesulfonamide;4-{[(2′-Methoxyphenyl)carbamoyl]amino}benzenesulfonamide;4-{[(2′-iso-Propylphenyl)carbamoyl]amino}benzenesulfonamide;4-{[(4′-iso-Propylphenyl)carbamoyl]amino}benzenesulfonamide;4-{[(4′-n-Butylphenyl ...

Подробнее
01-08-2013 дата публикации

METHOD OF INCREASING CROP YIELD AND CONTROLLING THE GROWTH OF WEEDS USING A POLYMER COMPOSITE FILM

Номер: US20130196851A1
Принадлежит: BAYER INNOVATION GMBH

Methods of protecting a crop from weed infestation, controlling weed growth, reducing fumigant dosage in crop protection, and reducing the growth of weeds by applying a polymer composite material with or without a biocide to soil, a crop, a vegetable, a weed, or combinations thereof are provided. In an aspect, the disclosure provides for a polymer composite material including a base polymer coated with: 1. A method of protecting a crop from weed infestation comprising applying a polymer composite material to soil , a crop , a weed , or combinations thereof , wherein said polymer composite material comprises a base polymer compound coated with(1) a first barrier layer;(2) a second layer comprising a biocide; and(3) a third protective layer.2. The method of claim 1 , wherein the weed is nutsedge.3. The method of claim 1 , wherein said first layer comprises a polyacrylate claim 1 , said second layer comprises gelatin claim 1 , and said third layer comprises gelatin and a hardener.4. The method of claim 1 , wherein said biocide comprises halosulfuronmethyl or ethoxysulfuron.5. The method of claim 1 , wherein crop safety is increased relative to a conventional plastic mulch film or virtually impenetrable film (VIF) with a biocide.6. The method of claim 5 , wherein the increased crop safety is more effective as compared to a conventional plastic mulch film or VIF applied over an equal area to which the same biocide active ingredient has been spray applied pre-emergence in the same amount as that present in the polymer composite material.7. The method of claim 1 , wherein crop yield is increased.9. The method of claim 8 , wherein the weed is nutsedge.10. The method of claim 8 , wherein the polymer composite material without a biocide reduces the growth of nutsedge at least 20% as compared to a conventional plastic mulch film or VIF without a biocide.11. The method of claim 8 , wherein said polymer composite material does not include a fumigant.12. The method of claim 8 , ...

Подробнее
01-08-2013 дата публикации

Extended-release formulation for reducing the frequency of urination and method of use thereof

Номер: US20130196956A1
Принадлежит: Wellesley Pharmaceuticals LLC

A method for reducing the frequency of urination is disclosed. The method comprises administering to a subject in need thereof an effective amount of a pharmaceutical composition comprising one or more analgesic agents and one or more α-blockers. In one embodiment, the one or more analgesic agents are formulated for extended-release.

Подробнее